subject: CHEBI:38545

object_name: Friedreich ataxia 1


subject: UNII:7ZX1Q9SJ1F

subject_name: NEMVALEUKIN ALFA

object_name: head and neck squamous cell carcinoma

tested_intervention: unsure


subject: UMLS:C4287715


subject: UMLS:C3890596

subject_name: Compound Kushen Injection

object_name: lung cancer

tested_intervention: yes


subject: UMLS:C3890596

object_name: lung neoplasm


subject: UMLS:C3890596

object_name: lung carcinoma


subject: UMLS:C3540708

subject_name: Antibiotics, Gynecological

object_name: esophageal disorder


subject: UMLS:C3540708

object_name: Achalasia


subject: MESH:D000904

subject_name: Antibiotics, Antitubercular


subject: MESH:D000904


subject: UMLS:C3540709

subject_name: antibiotics, intestinal


subject: UMLS:C3540709


subject: UMLS:C3540707

subject_name: Antibiotics FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE


subject: UMLS:C3540707


subject: UMLS:C0003232

subject_name: Antibiotics


subject: UMLS:C0003232


subject: UMLS:C3540704

subject_name: Antibiotics for systemic use


subject: UMLS:C3540704


subject: UMLS:C3540706

subject_name: Antibiotic throat preparations


subject: UMLS:C3540706


subject: UMLS:C3540710

subject_name: Antibiotics, ophthalmologic


subject: UMLS:C3540710


subject: UMLS:C3540705

subject_name: Antifungal Antibiotics, Topical


subject: UMLS:C3540705


subject: CHEBI:6121

subject_name: Ketamine

object_name: prostate carcinoma


subject: CHEBI:6121

object_name: prostate cancer


subject: CHEBI:6129

subject_name: Ketorolac


subject: CHEBI:6129


subject: CHEBI:7852

subject_name: Oxycodone


subject: CHEBI:7852


subject: UMLS:C5417895

subject_name: A2A Receptor Antagonist EOS100850

object_name: Adult Solid Neoplasm


subject: UMLS:C2981231

subject_name: fulranumab

object_name: chronic pain (diagnosis)


subject: UMLS:C2981231

object_name: Chronic pain


subject: CHEBI:6801

subject_name: Metformin

object_name: endocrine system disorder


subject: UMLS:C4721782

subject_name: Pegargiminase

object_name: Mesothelioma


subject: UMLS:C4721782

object_name: mesothelial neoplasm


subject: UMLS:C4721782

object_name: malignant mesothelioma


subject: UMLS:C1328192

subject_name: ADI PEG20


subject: UMLS:C1328192


subject: UMLS:C1328192


subject: CHEBI:6801

object_name: Hypoxic ischemic encephalopathy of newborn


subject: CHEBI:6801

object_name: premature birth (history)


subject: UMLS:C1509223

subject_name: Date Preparation

object_name: arteriosclerosis disorder


subject: UMLS:C1509223

object_name: atherosclerosis


subject: CHEBI:52717

subject_name: Bortezomib

object_name: pancreatic acinar cell carcinoma


subject: UNII:6GNT3Y5LMF

subject_name: LEVOFLOXACIN

object_name: appendicitis


subject: UNII:6GNT3Y5LMF

object_name: Appendicitis, CTCAE


subject: CHEBI:63598

subject_name: Levofloxacin


subject: CHEBI:63598


subject: PUBCHEM.COMPOUND:5066234

subject_name: Sucralose

object_name: Active dental caries (disorder)


subject: PUBCHEM.COMPOUND:5066234

object_name: Active Caries


subject: UMLS:C1742799

subject_name: Splenda


subject: UMLS:C1742799


subject: UNII:5BIA40E9ED

subject_name: lemongrass oil

object_name: Pain Disorder


subject: UMLS:C3256220

subject_name: Cymbopogon schoenanthus oil


subject: PUBCHEM.COMPOUND:156963654

subject_name: Sacituzumab govitecan

object_name: differentiated thyroid carcinoma


subject: PUBCHEM.COMPOUND:156963654

object_name: thyroid gland undifferentiated (anaplastic) carcinoma


subject: UNII:DA64T2C2IO

subject_name: SACITUZUMAB


subject: UNII:DA64T2C2IO


subject: UMLS:C3640943


subject: UMLS:C3640943


subject: CHEBI:34385

subject_name: Dalfampridine

object_name: nerve compression syndrome


subject: CHEBI:34385

object_name: hereditary neuropathy with liability to pressure palsies


subject: CHEBI:34385

object_name: carpal tunnel syndrome 1


subject: CHEBI:34385

object_name: carpal tunnel syndrome


subject: MESH:C420448

subject_name: sebacoyl dinalbuphine ester

object_name: Postoperative Pain, Chronic


subject: MESH:C420448

object_name: Post-Operative Pain


subject: UNII:2S9ZZM9Q9V

subject_name: Bevacizumab

object_name: Advanced Head and Neck Squamous Cell Carcinoma


subject: UNII:2S9ZZM9Q9V

object_name: Advanced Ovarian Clear Cell Adenocarcinoma


subject: UNII:2S9ZZM9Q9V

object_name: Recurrent Ovarian High Grade Serous Adenocarcinoma


subject: UNII:2S9ZZM9Q9V

object_name: Refractory Head and Neck Squamous Cell Carcinoma


subject: UNII:2S9ZZM9Q9V

object_name: Refractory Ovarian High Grade Serous Adenocarcinoma


subject: UNII:2S9ZZM9Q9V

object_name: Pathologic Stage IIIC Cutaneous Melanoma AJCC v8


subject: UNII:2S9ZZM9Q9V

object_name: Pathologic Stage IIID Cutaneous Melanoma AJCC v8


subject: UNII:2S9ZZM9Q9V

object_name: Pathologic Stage IIIA Cutaneous Melanoma AJCC v8


subject: UNII:2S9ZZM9Q9V

object_name: Pathologic Stage IIIB Cutaneous Melanoma AJCC v8


subject: UNII:2S9ZZM9Q9V

object_name: Refractory Ovarian Clear Cell Adenocarcinoma


subject: UNII:2S9ZZM9Q9V

object_name: Pathologic Stage III Cutaneous Melanoma AJCC v8


subject: UNII:2S9ZZM9Q9V

object_name: Stage IIIC2 Uterine Corpus Cancer AJCC v8


subject: UNII:2S9ZZM9Q9V

object_name: Stage IIIC1 Uterine Corpus Cancer AJCC v8


subject: UNII:2S9ZZM9Q9V

object_name: Stage IIIB Uterine Corpus Cancer AJCC v8


subject: UNII:2S9ZZM9Q9V

object_name: Stage IIIA Uterine Corpus Cancer AJCC v8


subject: UNII:2S9ZZM9Q9V

object_name: Stage IIIC Uterine Corpus Cancer AJCC v8


subject: UNII:2S9ZZM9Q9V

object_name: Stage IVB Uterine Corpus Cancer AJCC v8


subject: UNII:2S9ZZM9Q9V

object_name: Stage IVA Uterine Corpus Cancer AJCC v8


subject: UNII:2S9ZZM9Q9V

object_name: Stage III Uterine Corpus Cancer AJCC v8


subject: UNII:2S9ZZM9Q9V

object_name: Stage IV Uterine Corpus Cancer AJCC v8


subject: UNII:2S9ZZM9Q9V

object_name: Stage IIIA1 Ovarian Cancer AJCC v8


subject: UNII:2S9ZZM9Q9V

object_name: Stage IIIA2 Ovarian Cancer AJCC v8


subject: UNII:2S9ZZM9Q9V

object_name: Stage IVA Ovarian Cancer AJCC v8


subject: UNII:2S9ZZM9Q9V

object_name: Stage IVB Ovarian Cancer AJCC v8


subject: UNII:2S9ZZM9Q9V

object_name: Refractory Endometrial Carcinoma


subject: PUBCHEM.COMPOUND:42602260

subject_name: Capivasertib

object_name: Advanced Melanoma


subject: PUBCHEM.COMPOUND:42602260

object_name: Advanced Endometrial Carcinoma


subject: PUBCHEM.COMPOUND:42602260

object_name: Advanced Head and Neck Squamous Cell Carcinoma


subject: PUBCHEM.COMPOUND:42602260

object_name: Advanced Ovarian Clear Cell Adenocarcinoma


subject: PUBCHEM.COMPOUND:42602260

object_name: Recurrent Ovarian High Grade Serous Adenocarcinoma


subject: PUBCHEM.COMPOUND:42602260

object_name: Refractory Head and Neck Squamous Cell Carcinoma


subject: PUBCHEM.COMPOUND:42602260

object_name: Refractory Ovarian High Grade Serous Adenocarcinoma


subject: PUBCHEM.COMPOUND:42602260

object_name: Pathologic Stage IIIC Cutaneous Melanoma AJCC v8


subject: PUBCHEM.COMPOUND:42602260

object_name: Pathologic Stage IIID Cutaneous Melanoma AJCC v8


subject: PUBCHEM.COMPOUND:42602260

object_name: Pathologic Stage IIIA Cutaneous Melanoma AJCC v8


subject: PUBCHEM.COMPOUND:42602260

object_name: Pathologic Stage IIIB Cutaneous Melanoma AJCC v8


subject: PUBCHEM.COMPOUND:42602260

object_name: Refractory Ovarian Clear Cell Adenocarcinoma


subject: PUBCHEM.COMPOUND:42602260

object_name: Pathologic Stage III Cutaneous Melanoma AJCC v8


subject: PUBCHEM.COMPOUND:42602260

object_name: Pathologic Stage IV Cutaneous Melanoma AJCC v8


subject: PUBCHEM.COMPOUND:42602260

object_name: Clinical Stage III Cutaneous Melanoma AJCC v8


subject: PUBCHEM.COMPOUND:42602260

object_name: Stage IIIC2 Uterine Corpus Cancer AJCC v8


subject: PUBCHEM.COMPOUND:42602260

object_name: Stage IIIC1 Uterine Corpus Cancer AJCC v8


subject: PUBCHEM.COMPOUND:42602260

object_name: Stage IIIB Uterine Corpus Cancer AJCC v8


subject: PUBCHEM.COMPOUND:42602260

object_name: Stage IIIA Uterine Corpus Cancer AJCC v8


subject: PUBCHEM.COMPOUND:42602260

object_name: Stage IIIC Uterine Corpus Cancer AJCC v8


subject: PUBCHEM.COMPOUND:42602260

object_name: Clinical Stage IV Cutaneous Melanoma AJCC v8


subject: PUBCHEM.COMPOUND:42602260

object_name: Stage IVB Uterine Corpus Cancer AJCC v8


subject: PUBCHEM.COMPOUND:42602260

object_name: Stage IVA Uterine Corpus Cancer AJCC v8


subject: PUBCHEM.COMPOUND:42602260

object_name: Stage III Uterine Corpus Cancer AJCC v8


subject: PUBCHEM.COMPOUND:42602260

object_name: Stage IV Uterine Corpus Cancer AJCC v8


subject: PUBCHEM.COMPOUND:42602260

object_name: Stage IIIA1 Ovarian Cancer AJCC v8


subject: PUBCHEM.COMPOUND:42602260

object_name: Stage IIIC Ovarian Cancer AJCC v8


subject: PUBCHEM.COMPOUND:42602260

object_name: Stage IIIA2 Ovarian Cancer AJCC v8


subject: PUBCHEM.COMPOUND:42602260

object_name: Stage IIIA Ovarian Cancer AJCC v8


subject: PUBCHEM.COMPOUND:42602260

object_name: Stage IIIB Ovarian Cancer AJCC v8


subject: PUBCHEM.COMPOUND:42602260

object_name: Stage III Ovarian Cancer AJCC v8


subject: PUBCHEM.COMPOUND:42602260

object_name: Stage IVA Ovarian Cancer AJCC v8


subject: PUBCHEM.COMPOUND:42602260

object_name: Stage IVB Ovarian Cancer AJCC v8


subject: PUBCHEM.COMPOUND:42602260

object_name: Stage IV Ovarian Cancer AJCC v8


subject: PUBCHEM.COMPOUND:42602260

object_name: Refractory Endometrial Carcinoma


subject: PUBCHEM.COMPOUND:42602260

object_name: Refractory Melanoma


subject: PUBCHEM.COMPOUND:42602260

object_name: bone chondrosarcoma


subject: PUBCHEM.COMPOUND:42602260

object_name: chondrosarcoma


subject: UMLS:C5554571

subject_name: Glutaminase-1 Inhibitor IACS-6274

object_name: Advanced Melanoma


subject: UMLS:C5554571

object_name: Advanced Malignant Solid Neoplasm


subject: UMLS:C5554571

object_name: Advanced Endometrial Carcinoma


subject: UMLS:C5554571

object_name: Advanced Head and Neck Squamous Cell Carcinoma


subject: UMLS:C5554571

object_name: Advanced Ovarian Clear Cell Adenocarcinoma


subject: UMLS:C5554571

object_name: Recurrent Ovarian High Grade Serous Adenocarcinoma


subject: UMLS:C5554571

object_name: Refractory Head and Neck Squamous Cell Carcinoma


subject: UMLS:C5554571

object_name: Refractory Ovarian High Grade Serous Adenocarcinoma


subject: UMLS:C5554571

object_name: Pathologic Stage IIIC Cutaneous Melanoma AJCC v8


subject: UMLS:C5554571

object_name: Pathologic Stage IIID Cutaneous Melanoma AJCC v8


subject: UMLS:C5554571

object_name: Pathologic Stage IIIA Cutaneous Melanoma AJCC v8


subject: UMLS:C5554571

object_name: Pathologic Stage IIIB Cutaneous Melanoma AJCC v8


subject: UMLS:C5554571

object_name: Refractory Ovarian Clear Cell Adenocarcinoma


subject: UMLS:C5554571

object_name: Pathologic Stage III Cutaneous Melanoma AJCC v8


subject: UMLS:C5554571

object_name: Pathologic Stage IV Cutaneous Melanoma AJCC v8


subject: UMLS:C5554571

object_name: Clinical Stage III Cutaneous Melanoma AJCC v8


subject: UMLS:C5554571

object_name: Stage IIIC2 Uterine Corpus Cancer AJCC v8


subject: UMLS:C5554571

object_name: Stage IIIC1 Uterine Corpus Cancer AJCC v8


subject: UMLS:C5554571

object_name: Stage IIIB Uterine Corpus Cancer AJCC v8


subject: UMLS:C5554571

object_name: Stage IIIA Uterine Corpus Cancer AJCC v8


subject: UMLS:C5554571

object_name: Stage IIIC Uterine Corpus Cancer AJCC v8


subject: UMLS:C5554571

object_name: Clinical Stage IV Cutaneous Melanoma AJCC v8


subject: UMLS:C5554571

object_name: Stage IVB Uterine Corpus Cancer AJCC v8


subject: UMLS:C5554571

object_name: Stage IVA Uterine Corpus Cancer AJCC v8


subject: UMLS:C5554571

object_name: Stage III Uterine Corpus Cancer AJCC v8


subject: UMLS:C5554571

object_name: Stage IV Uterine Corpus Cancer AJCC v8


subject: UMLS:C5554571

object_name: Stage IIIA1 Ovarian Cancer AJCC v8


subject: UMLS:C5554571

object_name: Stage IIIC Ovarian Cancer AJCC v8


subject: UMLS:C5554571

object_name: Stage IIIA2 Ovarian Cancer AJCC v8


subject: UMLS:C5554571

object_name: Stage IIIA Ovarian Cancer AJCC v8


subject: UMLS:C5554571

object_name: Stage IIIB Ovarian Cancer AJCC v8


subject: UMLS:C5554571

object_name: Stage III Ovarian Cancer AJCC v8


subject: UMLS:C5554571

object_name: Stage IVA Ovarian Cancer AJCC v8


subject: UMLS:C5554571

object_name: Stage IVB Ovarian Cancer AJCC v8


subject: UMLS:C5554571

object_name: Stage IV Ovarian Cancer AJCC v8


subject: UMLS:C5554571

object_name: Refractory Endometrial Carcinoma


subject: UMLS:C5554571

object_name: Refractory Melanoma


subject: UMLS:C5554571

object_name: bone chondrosarcoma


subject: UMLS:C5554571

object_name: chondrosarcoma


subject: CHEBI:45863

subject_name: Paclitaxel

object_name: Advanced Melanoma


subject: CHEBI:45863

object_name: Advanced Head and Neck Squamous Cell Carcinoma


subject: CHEBI:45863

object_name: Advanced Ovarian Clear Cell Adenocarcinoma


subject: CHEBI:45863

object_name: Recurrent Ovarian High Grade Serous Adenocarcinoma


subject: CHEBI:45863

object_name: Refractory Head and Neck Squamous Cell Carcinoma


subject: CHEBI:45863

object_name: Refractory Ovarian High Grade Serous Adenocarcinoma


subject: CHEBI:45863

object_name: Refractory Ovarian Clear Cell Adenocarcinoma


subject: CHEBI:45863


subject: CHEBI:45863


subject: CHEBI:45863


subject: CHEBI:45863


subject: CHEBI:135967

subject_name: Casopitant

object_name: Urinary Urgency


subject: UMLS:C1831798


subject: CHEBI:52261

subject_name: rose bengal

object_name: melanoma


subject: CHEBI:74698

subject_name: Met-Arg

object_name: measles


subject: CHEBI:74698

object_name: rubella


subject: PR:000011407

subject_name: mineralocorticoid receptor


subject: PR:000011407


subject: UMLS:C0042210

subject_name: Vaccines


subject: UMLS:C0042210


subject: UMLS:C5399710

subject_name: Vaccine [APC]


subject: UMLS:C5399710


subject: CHEBI:231605

subject_name: Telaglenastat

object_name: cervical cancer


subject: CHEBI:231605

object_name: cervical carcinoma


subject: CHEBI:231605

object_name: Advanced Cervical Carcinoma


subject: CHEBI:7459

subject_name: Naloxone

object_name: AIDS


subject: MESH:D011819

subject_name: Rabies Vaccines

object_name: malaria


subject: CHEMBL.COMPOUND:CHEMBL2107909

subject_name: RABIES VACCINE


subject: CHEBI:7903

subject_name: Pamidronic acid

object_name: bone Paget disease


subject: UMLS:C5555610

subject_name: PKMYT1 Inhibitor RP-6306

object_name: Recurrent Endometrial Cancer


subject: UMLS:C5555610

object_name: Recurrent ovarian cancer


subject: UMLS:C5555610

object_name: Disseminated Malignant Neoplasm


subject: UMLS:C5555610

object_name: Embolism, Tumor


subject: UMLS:C5555610

object_name: Neoplasm Metastasis


subject: CHEBI:10100

subject_name: Zafirlukast

object_name: Cat Allergy


subject: CHEBI:10100

object_name: History of - cat allergy


subject: UMLS:C5554944

subject_name: Pan-FGFR Inhibitor ICP-192

object_name: bladder transitional cell carcinoma


subject: UMLS:C5666965

subject_name: Anti-PD-L1/Anti-LAG-3 Bispecific Antibody ABL501

object_name: Advanced Malignant Solid Neoplasm


subject: CHEBI:63610

subject_name: Misoprostol

object_name: Uterine hemorrhage


subject: CHEBI:63610

object_name: Uterine Hemorrhage, CTCAE


subject: CHEBI:63631

subject_name: Topiramate

object_name: Lennox-Gastaut syndrome


subject: CHEBI:67272

subject_name: Perifosine

object_name: chondrosarcoma


subject: CHEBI:67272

object_name: alveolar soft part sarcoma


subject: CHEBI:100241

subject_name: Ciprofloxacin

object_name: bladder tumor


subject: CHEBI:100241

object_name: urinary bladder carcinoma


subject: CHEBI:100241

object_name: urinary bladder cancer


subject: CHEBI:100241

object_name: childhood bladder carcinoma


subject: CHEBI:3535

subject_name: Cephalexin


subject: CHEBI:3535


subject: CHEBI:3535


subject: CHEBI:3535


subject: CHEBI:3534


subject: CHEBI:3534


subject: CHEBI:3534


subject: CHEBI:3534


subject: UNII:I5I8VB78VT

subject_name: Erenumab

object_name: Post-Traumatic Headache


subject: UNII:T1JP1KYU9O

subject_name: Flortaucipir F-18

object_name: Chronic Traumatic Encephalopathy


subject: UNII:T1JP1KYU9O

object_name: dementia pugilistica


subject: UNII:6867Q6IKOD

subject_name: FLORBETAPIR


subject: UNII:6867Q6IKOD


subject: UMLS:C2348498

object_name: childhood acute lymphoblastic leukemia


subject: UMLS:C2348498

object_name: childhood acute myeloid leukemia


subject: CHEBI:90217

subject_name: Quizartinib


subject: DRUGBANK:DB16515

object_name: acute respiratory distress syndrome


subject: DRUGBANK:DB16515

object_name: adult acute respiratory distress syndrome


subject: DRUGBANK:DB16515


subject: PUBCHEM.COMPOUND:5281767

subject_name: CURCUMIN

object_name: Well adult


subject: UNII:BRJ718SA03

object_name: herpes zoster


subject: UNII:BRJ718SA03

object_name: postherpetic neuralgia


subject: UMLS:C2742997


subject: UMLS:C2742997


subject: UNII:5S371K6132

subject_name: Rivoceranib

object_name: overall survival


subject: UMLS:C4085979


subject: UMLS:C4085979

object_name: poisoning


subject: UNII:1Z08G7438A

subject_name: Dovramilast

object_name: cutaneous lupus erythematosus


subject: CHEMBL.COMPOUND:CHEMBL3545216

object_name: osteoarthritis, knee


subject: PUBCHEM.COMPOUND:2735

subject_name: Provitina

object_name: Recurrent lower respiratory tract infections


subject: PUBCHEM.COMPOUND:10883523

subject_name: vitamin D3


subject: UMLS:C3265062


subject: CHEBI:27300

subject_name: Ergocalciferol


subject: PR:000005280

subject_name: cyclin-dependent kinase inhibitor 3

object_name: opiate dependence


subject: PR:000010986

subject_name: napsin-A


subject: PR:000009240

subject_name: kidney androgen-regulated protein


subject: UMLS:C0591175

subject_name: Betaloc

object_name: Chronic total occlusion of coronary artery


subject: UMLS:C0591175

object_name: coronary artery disorder


subject: UMLS:C0591175

object_name: coronary atherosclerosis


subject: CHEBI:6904

subject_name: Metoprolol


subject: CHEBI:6904


subject: CHEBI:39548

subject_name: Atorvastatin


subject: CHEBI:38545

subject_name: Rosuvastatin


subject: CHEBI:68558

subject_name: Ticagrelor


subject: PUBCHEM.COMPOUND:73151030

subject_name: Empagliflozin

object_name: Myocardial Reperfusion Injury


subject: UMLS:C0086333

subject_name: Gammagard

object_name: habitual spontaneous abortion


subject: UMLS:C0086333

object_name: pregnancy loss, recurrent, susceptibility to, 1


subject: PUBCHEM.COMPOUND:184196

object_name: non-small cell lung carcinoma


subject: UMLS:C4048807


subject: UMLS:C4053486

subject_name: Recombinant Super-Compound Interferon

object_name: colon carcinoma


subject: UMLS:C4053486

object_name: colorectal cancer


subject: UMLS:C4053486

object_name: colon cancer


subject: UMLS:C4053486

object_name: liver carcinoma


subject: UMLS:C4053486

object_name: melanoma


subject: UMLS:C4053486

object_name: renal cell carcinoma


subject: UMLS:C4053486


subject: CHEBI:17061

subject_name: D-Glutamine

object_name: Inflammatory Response


subject: CHEBI:17061

object_name: multiple organ dysfunction syndrome


subject: CHEBI:17061

object_name: Death Due to Multi-Organ Failure Not Associated with More Specific Term, CTCAE


subject: CHEBI:17061

object_name: Multi-Organ Failure, CTCAE


subject: CHEBI:28300

subject_name: glutamine


subject: CHEBI:28300


subject: CHEBI:28300


subject: CHEBI:28300


subject: CHEBI:18050

subject_name: L-Glutamine


subject: CHEBI:18050


subject: CHEBI:18050


subject: CHEBI:18050


subject: GTOPDB:9110

object_name: Stomach cancer


subject: GTOPDB:9110

object_name: gastric cancer


subject: UMLS:C2703205


subject: UMLS:C2703205


subject: CHEBI:6067

subject_name: Isotretinoin

object_name: skin melanoma


subject: PUBCHEM.COMPOUND:9805430

subject_name: Apadenoson

object_name: cardiovascular disorder


subject: UNII:BTS1Y6777M


subject: UNII:B2K5L1L8S9

subject_name: Surufatinib

object_name: differentiated thyroid carcinoma


subject: CHEMBL.COMPOUND:CHEMBL2108391

subject_name: HONEY

object_name: Poor quality sleep


subject: PUBCHEM.COMPOUND:43805

subject_name: Oxaliplatin

object_name: acute myeloid leukemia by FAB classification


subject: PUBCHEM.COMPOUND:43805

object_name: acute myeloid leukemia


subject: PUBCHEM.COMPOUND:43805

object_name: Myelodysplasia


subject: UMLS:C1314429

subject_name: INJECTION, OXALIPLATIN, 0.5 MG ADMINISTERED


subject: UMLS:C1314429


subject: UMLS:C1314429


subject: CHEBI:41879

subject_name: Dexamethasone

object_name: coronary stenosis


subject: CHEBI:27732

subject_name: Caffeine

object_name: chronic obstructive pulmonary disease


subject: UMLS:C5418101

object_name: metastatic colorectal cancer


subject: CHEBI:40279

subject_name: Allopurinol

object_name: Vasodilation disorder


subject: CHEBI:2781

subject_name: Apocynin


subject: CHEBI:180664

subject_name: Tempol


subject: CHEBI:51098

subject_name: Motesanib

object_name: plasma cell myeloma


subject: CHEMBL.COMPOUND:CHEMBL2107856

subject_name: IMETELSTAT


subject: CHEBI:124965

subject_name: Opaganib

object_name: Coronavinae infectious disease


subject: UMLS:C2933331

subject_name: Yeliva


subject: PUBCHEM.COMPOUND:10458325

subject_name: tesevatinib

object_name: autosomal recessive polycystic kidney disease


subject: CHEBI:167674

subject_name: Tesevatinib


subject: CHEBI:15365

subject_name: Aspirin

object_name: Rash and Dermatitis Associated with Chemoradiation, CTCAE


subject: CHEBI:15365

object_name: Locally Advanced Malignant Neoplasm


subject: CHEBI:15365

object_name: rectum adenocarcinoma


subject: CHEBI:94531

subject_name: belinostat

object_name: cancer of unknown primary site


subject: UMLS:C2930557

object_name: arteriosclerosis disorder


subject: UMLS:C2930557

object_name: atherosclerosis


subject: UNII:G6UF363ECX

object_name: Cytopenia


subject: UNII:G6UF363ECX

object_name: thrombocytopenia


subject: UNII:G6UF363ECX

object_name: anemia


subject: UNII:G6UF363ECX

object_name: Anemia, CTCAE


subject: UMLS:C4308025

subject_name: AAA 617


subject: UMLS:C4308025


subject: UMLS:C4308025


subject: UMLS:C4308025


subject: CHEBI:90936

subject_name: Alectinib

object_name: Non-small cell lung cancer recurrent


subject: MESH:C546417

subject_name: Neuroaid

object_name: spinal cord injury


subject: CHEBI:85182

subject_name: Dasabuvir

object_name: Decompensated cirrhosis of liver


subject: PUBCHEM.COMPOUND:76192587

subject_name: Ombitasvir


subject: CHEBI:85188

subject_name: paritaprevir


subject: CHEBI:45409

subject_name: Ritonavir


subject: CHEBI:94463


subject: CHEBI:63580

subject_name: Ribavirin


subject: CHEMBL.COMPOUND:CHEMBL2108417

subject_name: DIPHTHERIA ANTITOXIN

object_name: Safety Issues


subject: UMLS:C0695115

subject_name: Diphtheria antitoxin, equine, any route


subject: UMLS:C0012547

subject_name: diphtheria antitoxin


subject: UMLS:C0002525

subject_name: Amino Acids, Essential


subject: UMLS:C0003442

subject_name: lymphocyte immune globulin, anti-thymocyte globulin

object_name: immunodeficiency disease


subject: UMLS:C0003442

object_name: inborn error of immunity


subject: UMLS:C0003442

object_name: X-linked lymphoproliferative syndrome


subject: UMLS:C0003442

object_name: Chediak-Higashi syndrome


subject: UMLS:C0003442

object_name: Griscelli syndrome


subject: CHEBI:201431

subject_name: Cyclosporin H

object_name: Langerhans cell histiocytosis


subject: CHEBI:201431


subject: CHEBI:201431


subject: CHEBI:201431


subject: CHEBI:4031

subject_name: Cyclosporine


subject: CHEBI:4031


subject: CHEBI:4031


subject: CHEBI:4031


subject: PUBCHEM.COMPOUND:3367


subject: CHEBI:63599

subject_name: Fludarabine


subject: UMLS:C0085297

subject_name: immunoglobulins, intravenous


subject: UMLS:C0085297

object_name: hemophagocytic syndrome


subject: UMLS:C0085297


subject: UMLS:C0085297


subject: CHEBI:168396

subject_name: Mycophenolic acid


subject: CHEBI:168396


subject: CHEBI:168396


subject: CHEBI:8764

subject_name: Mycophenolate mofetil


subject: CHEBI:8764


subject: CHEBI:8764


subject: UMLS:C0521942

subject_name: Angiotensin II receptor antagonist

object_name: brain infarction


subject: CHEBI:35457

subject_name: EC 3.4.15.1 (peptidyl-dipeptidase A) inhibitor


subject: UMLS:C0003015


subject: UMLS:C0384570

subject_name: Recombinant Human Growth Hormone

object_name: growth hormone treatment


subject: UMLS:C2825029

subject_name: Recombinant Human Growth Hormone [EPC]


subject: UMLS:C0936150

subject_name: artemether / lumefantrine

object_name: HIV Coinfection


subject: CHEBI:44915

subject_name: Propofol

object_name: Drug usage


subject: CHEBI:9241

subject_name: Spironolactone

object_name: diabetic maculopathy


subject: CHEBI:35366

subject_name: fatty acid

object_name: hypertrophy


subject: CHEMBL.COMPOUND:CHEMBL4594307

subject_name: AMYLOPECTIN

object_name: Prediabetes


subject: CHEBI:28057

subject_name: Amylopectin


subject: CHEBI:31625

subject_name: Fluorometholone

object_name: OPTN-related open angle glaucoma


subject: CHEBI:31625

object_name: open-angle glaucoma


subject: CHEBI:31625

object_name: ocular hypertension


subject: CHEBI:31625

object_name: Ocular hypertension


subject: UMLS:C2917659

subject_name: Acetaminophen [EPC]

object_name: Impacted third molar tooth


subject: CHEBI:28171

object_name: Cancer Remission


subject: CHEBI:28171

object_name: Remission


subject: CHEBI:28171

object_name: Fatigue, CTCAE 5.0


subject: CHEBI:28171

object_name: Fatigue


subject: CHEBI:28171

object_name: inflammatory bowel disease 1


subject: CHEBI:28171

object_name: Crohn disease


subject: CHEBI:28171

object_name: ulcerative colitis


subject: UMLS:C1880230

subject_name: 5-hydroxytryptophan, DL-


subject: UMLS:C1880230


subject: UMLS:C1880230


subject: UMLS:C1880230


subject: UMLS:C1880230


subject: UMLS:C1880230


subject: UMLS:C1880230


subject: CHEBI:17780

subject_name: Oxitriptan


subject: CHEBI:17780


subject: CHEBI:17780


subject: CHEBI:17780


subject: CHEBI:17780


subject: CHEBI:17780


subject: CHEBI:17780


subject: GTOPDB:13791

subject_name: sacituzumab tirumotecan

object_name: Solid Neoplasm


subject: UNII:3DV5TD1VL3

subject_name: SACITUZUMAB TIRUMOTECAN


subject: CHEBI:15372

object_name: pervasive developmental disorder


subject: CHEBI:15372

object_name: autism spectrum disorder


subject: PUBCHEM.COMPOUND:129630809

subject_name: trihydroxybutyrophenone


subject: PUBCHEM.COMPOUND:129630809


subject: CHEBI:173969


subject: CHEBI:173969


subject: CHEBI:59560

subject_name: Sapropterin


subject: CHEBI:59560


subject: PUBCHEM.COMPOUND:10011857

subject_name: Fluorocholine F-18

object_name: prostate carcinoma


subject: PUBCHEM.COMPOUND:10011857

object_name: prostate cancer


subject: UMLS:C1872806


subject: UMLS:C1872806


subject: UNII:5S371K6132

subject_name: Rivoceranib

object_name: Drug problem


subject: CHEBI:137259

subject_name: Ile-Glu

object_name: poisoning


subject: CHEBI:137259


subject: UNII:01KC87F8FE

object_name: skin melanoma


subject: CHEBI:3423

subject_name: Carmustine


subject: CHEBI:25805

subject_name: oxygen atom

object_name: ST Elevation Myocardial Infarction


subject: CHEBI:15379

subject_name: Oxygen


subject: CHEBI:231679

subject_name: ipilimumab

object_name: Carcinoma liver resectable


subject: CHEBI:7915

subject_name: Pantoprazole

object_name: sleep disorder


subject: CHEBI:41423

subject_name: Celecoxib

object_name: Bleeding ulcer


subject: CHEBI:50275

subject_name: Esomeprazole

object_name: arthritis


subject: CHEBI:50275

object_name: Arthritis, CTCAE


subject: CHEBI:50275


subject: CHEBI:77260

subject_name: Omeprazole


subject: CHEBI:77260


subject: CHEBI:77260


subject: UMLS:C5204220

object_name: Disseminated Malignant Neoplasm


subject: UMLS:C5204220

object_name: Embolism, Tumor


subject: UMLS:C5204220

object_name: Neoplasm Metastasis


subject: UMLS:C5204220

object_name: Childhood Solid Neoplasm


subject: UMLS:C5204220

object_name: Adult Solid Neoplasm


subject: UMLS:C5204220

object_name: Solid Neoplasm


subject: CHEBI:145431

subject_name: Indisulam

object_name: cancer


subject: CHEBI:145431

object_name: neoplasm


subject: UMLS:C0879271


subject: UMLS:C0879271


subject: UNII:C137DTR5RG

subject_name: THEOPHYLLINE

object_name: viral disease


subject: UNII:C137DTR5RG

object_name: Theophylline causing adverse effects in therapeutic use


subject: UNII:C137DTR5RG

object_name: anosmia


subject: UNII:C137DTR5RG

object_name: Parosmia


subject: UNII:C137DTR5RG

object_name: Anosmia, CTCAE


subject: CHEBI:28177

subject_name: Theophylline


subject: CHEBI:28177


subject: CHEBI:28177


subject: CHEBI:28177


subject: CHEBI:28177


subject: DRUGBANK:DB18160

object_name: spinocerebellar ataxia type 1


subject: DRUGBANK:DB18160

object_name: Machado-Joseph disease


subject: DRUGBANK:DB18160

object_name: Huntington disease


subject: UMLS:C3651256

subject_name: Aurstat

object_name: Pruritus, CTCAE


subject: UMLS:C3651256

object_name: Pruritus


subject: UMLS:C3651256

object_name: atopic eczema


subject: UMLS:C1328149

object_name: head and neck squamous cell carcinoma


subject: CHEBI:74538

subject_name: Leu-Gly-Gly

object_name: milk allergy


subject: UMLS:C0721277

subject_name: LGG brand of Dyphylline/Guaifenesin


subject: UMLS:C1832078

subject_name: LGG Lactobacillus rhamnosus GG


subject: CHEBI:50673

subject_name: Methimazole

object_name: Melasma


subject: CHEBI:5613

subject_name: Haloperidol

object_name: complications of organ transplant stem cells


subject: UMLS:C0678113

subject_name: Actilyse

object_name: Stroke (heart beat)


subject: UMLS:C0678113

object_name: Stroke, CTCAE


subject: CHEBI:16349

subject_name: Citrulline

object_name: Blood Pressure Finding


subject: CHEBI:16349

object_name: Systemic arterial pressure


subject: UNII:D733ET3F9O

subject_name: crisantaspase

object_name: Infant T Acute Lymphoblastic Leukemia


subject: UNII:D733ET3F9O

object_name: Pre T-ALL


subject: UNII:D733ET3F9O

object_name: T-cell childhood acute lymphocytic leukemia


subject: UNII:D733ET3F9O

object_name: T-cell adult acute lymphocytic leukemia


subject: UMLS:C0591457

subject_name: Erwinase


subject: UMLS:C0591457


subject: UMLS:C0591457


subject: UMLS:C0591457


subject: CHEBI:64816

object_name: B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative


subject: CHEBI:4911

subject_name: Etoposide


subject: UNII:PVI5M0M1GW

subject_name: Filgrastim


subject: PR:000005932

subject_name: granulocyte colony-stimulating factor


subject: UNII:3A58010674

subject_name: Pegfilgrastim


subject: UNII:3A58010674


subject: UNII:3A58010674


subject: UNII:3A58010674


subject: UNII:3A58010674


subject: CHEBI:143658


subject: CHEBI:143658


subject: CHEBI:31617

subject_name: fludeoxyglucose (18F)

object_name: Seizure Related to COVID-19


subject: CHEBI:31617

object_name: epilepsy


subject: CHEBI:31617

object_name: visual epilepsy


subject: CHEBI:31617

object_name: metabolic disease


subject: CHEBI:31617

object_name: focal epilepsy


subject: CHEBI:31617

object_name: generalized epilepsy


subject: CHEBI:31617

object_name: idiopathic generalized epilepsy


subject: CHEBI:31617

object_name: West syndrome


subject: CHEBI:31617

object_name: Infantile Spasm


subject: CHEBI:75958

subject_name: solution

object_name: glaucoma


subject: CHEBI:75958

object_name: Glaucoma, CTCAE


subject: UMLS:C0037633

subject_name: Solutions


subject: UMLS:C0037633


subject: CHEBI:15365

subject_name: Aspirin

object_name: platelet function test


subject: UMLS:C1446442

subject_name: Curcuma longa antigen


subject: DRUGBANK:DB14276

subject_name: Turmeric


subject: MESH:C403258

subject_name: si-wu-tang


subject: UMLS:C0911601


subject: CHEBI:91825

subject_name: Dapt

object_name: arteriosclerosis disorder


subject: CHEBI:91825

object_name: atherosclerosis


subject: UNII:949B9ZMO7M

subject_name: Diaminopropanol tetraacetic acid


subject: UNII:949B9ZMO7M


subject: PUBCHEM.COMPOUND:6438565


subject: PUBCHEM.COMPOUND:6438565


subject: CHEBI:132922

object_name: Fetal Death


subject: CHEBI:132922

object_name: pelvic pain on the left


subject: CHEBI:132922

object_name: pelvic pain occurs with urination


subject: CHEBI:132922

object_name: pelvic pain occurs with bowel movement


subject: CHEBI:132922

object_name: pelvic pain decreasing in severity


subject: CHEBI:132922

object_name: Pelvic pain female


subject: CHEBI:132922

object_name: pelvic pain increasing in severity


subject: CHEBI:132922

object_name: male pelvic pain


subject: CHEBI:132922

object_name: pelvic pain to the rear


subject: CHEBI:132922

object_name: pelvic pain on the right


subject: CHEBI:132922

object_name: pelvic pain decreasing in frequency


subject: CHEBI:132922

object_name: Pelvic pain


subject: CHEBI:132922

object_name: Pelvic Pain, CTCAE 5.0


subject: CHEBI:132922

object_name: pelvic pain causes awakening at night


subject: CHEBI:132922

object_name: pelvic pain increasing in frequency


subject: CHEBI:132922

object_name: pelvic pain occurs with intercourse


subject: CHEBI:132922

object_name: pelvic pain in front


subject: CHEBI:43415

subject_name: Dexibuprofen

object_name: Fetal Death


subject: CHEBI:43415

object_name: pelvic pain on the left


subject: CHEBI:43415

object_name: pelvic pain occurs with urination


subject: CHEBI:43415

object_name: pelvic pain occurs with bowel movement


subject: CHEBI:43415

object_name: pelvic pain decreasing in severity


subject: CHEBI:43415

object_name: Pelvic pain female


subject: CHEBI:43415

object_name: pelvic pain increasing in severity


subject: CHEBI:43415

object_name: male pelvic pain


subject: CHEBI:43415

object_name: pelvic pain to the rear


subject: CHEBI:43415

object_name: pelvic pain on the right


subject: CHEBI:43415

object_name: pelvic pain decreasing in frequency


subject: CHEBI:43415

object_name: Pelvic pain


subject: CHEBI:43415

object_name: Pelvic Pain, CTCAE 5.0


subject: CHEBI:43415

object_name: pelvic pain causes awakening at night


subject: CHEBI:43415

object_name: pelvic pain increasing in frequency


subject: CHEBI:43415

object_name: pelvic pain occurs with intercourse


subject: CHEBI:43415

object_name: pelvic pain in front


subject: CHEBI:5855

subject_name: Ibuprofen


subject: CHEBI:5855


subject: CHEBI:5855


subject: CHEBI:5855


subject: CHEBI:5855


subject: CHEBI:5855


subject: CHEBI:5855


subject: CHEBI:5855


subject: CHEBI:5855


subject: CHEBI:5855


subject: CHEBI:5855


subject: CHEBI:5855


subject: CHEBI:5855


subject: CHEBI:5855


subject: CHEBI:5855


subject: CHEBI:5855


subject: UMLS:C1705207

subject_name: Endostar

object_name: suppressor of tumorigenicity 3


subject: CHEBI:74705

subject_name: Met-Leu

object_name: Funnel Chest


subject: PR:000009425

subject_name: killer cell lectin-like receptor subfamily F member 1


subject: PR:000016318

subject_name: thrombopoietin


subject: CHEBI:28838

subject_name: Lutein

object_name: oculocutaneous albinism


subject: CHEBI:28838

object_name: ocular albinism


subject: CHEBI:27547

subject_name: Zeaxanthin


subject: CHEBI:27547


subject: UMLS:C5392518

object_name: oral cavity carcinoma


subject: UMLS:C5392518

object_name: lip and oral cavity carcinoma


subject: CHEBI:6129

subject_name: Ketorolac

object_name: migraine with aura


subject: CHEBI:6129

object_name: Common Migraine


subject: PUBCHEM.COMPOUND:450772

object_name: melanoma


subject: UNII:2X1K91UT6N

subject_name: Alovudine F-18


subject: CHEBI:49140


subject: CHEBI:31617

subject_name: fludeoxyglucose (18F)


subject: CHEBI:8499

subject_name: Propranolol

object_name: heroin dependence


subject: KEGG.COMPOUND:C00735

subject_name: Cortisol


subject: CHEBI:17650

subject_name: Hydrocortisone


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab

object_name: Locally Advanced Ureter Urothelial Carcinoma


subject: UNII:DPT0O3T46P

object_name: Transitional cell cancer of the renal pelvis and ureter localised


subject: UNII:DPT0O3T46P

object_name: Stage III Ureter Cancer AJCC v7


subject: UNII:DPT0O3T46P

object_name: Stage II Ureter Cancer AJCC v7


subject: UNII:DPT0O3T46P

object_name: Stage III Renal Pelvis and Ureter Cancer AJCC v7


subject: UNII:DPT0O3T46P

object_name: Stage II Renal Pelvis and Ureter Cancer AJCC v7


subject: UMLS:C4744543

object_name: renal cell adenocarcinoma


subject: UMLS:C4744543

object_name: kidney cancer


subject: UMLS:C4744543

object_name: renal cell carcinoma


subject: UMLS:C4744543

object_name: childhood kidney cell carcinoma


subject: UMLS:C4744543

object_name: ovarian cancer


subject: UMLS:C4744543

object_name: ovarian neoplasm


subject: UMLS:C4744543

object_name: ovarian carcinoma


subject: UMLS:C4744543

object_name: bladder tumor


subject: UMLS:C4744543

object_name: urinary bladder carcinoma


subject: UMLS:C4744543

object_name: urinary bladder cancer


subject: UMLS:C4744543

object_name: childhood bladder carcinoma


subject: UMLS:C4744543

object_name: cervical cancer


subject: UMLS:C4744543

object_name: cervical carcinoma


subject: UMLS:C4744543

object_name: colorectal cancer


subject: UMLS:C4744543

object_name: colorectal carcinoma


subject: UMLS:C4744543

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: UMLS:C4744543

object_name: pancreatic neoplasm


subject: UMLS:C4744543

object_name: exocrine pancreatic carcinoma


subject: UMLS:C4744543

object_name: malignant pancreatic neoplasm


subject: UMLS:C4744543

object_name: endometrial cancer


subject: UMLS:C4744543

object_name: uterine corpus cancer


subject: UMLS:C4744543

object_name: endometrial carcinoma


subject: UMLS:C4744543

object_name: non-small cell lung carcinoma


subject: UMLS:C4744543

object_name: head and neck squamous cell carcinoma


subject: UMLS:C4744543

object_name: triple-negative breast carcinoma


subject: UMLS:C4744543

object_name: Triple-Negative Breast Cancer Finding


subject: UMLS:C4744543

object_name: lymphoma, non-Hodgkin, familial


subject: UMLS:C4744543

object_name: non-Hodgkin lymphoma


subject: UMLS:C4744543

object_name: Adult Non-Hodgkin Lymphoma


subject: UMLS:C4744543

object_name: Childhood Non-Hodgkin Lymphoma


subject: UMLS:C4744543

object_name: malignant soft tissue neoplasm


subject: UMLS:C4744543

object_name: sarcoma


subject: UNII:8KFO2187CP

subject_name: Ciforadenant

object_name: ovarian cancer


subject: UNII:8KFO2187CP

object_name: ovarian neoplasm


subject: UNII:8KFO2187CP

object_name: ovarian carcinoma


subject: UNII:8KFO2187CP

object_name: bladder tumor


subject: UNII:8KFO2187CP

object_name: urinary bladder carcinoma


subject: UNII:8KFO2187CP

object_name: urinary bladder cancer


subject: UNII:8KFO2187CP

object_name: childhood bladder carcinoma


subject: UNII:8KFO2187CP

object_name: cervical cancer


subject: UNII:8KFO2187CP

object_name: cervical carcinoma


subject: UNII:8KFO2187CP

object_name: colorectal cancer


subject: UNII:8KFO2187CP

object_name: colorectal carcinoma


subject: UNII:8KFO2187CP

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: UNII:8KFO2187CP

object_name: pancreatic neoplasm


subject: UNII:8KFO2187CP

object_name: exocrine pancreatic carcinoma


subject: UNII:8KFO2187CP

object_name: malignant pancreatic neoplasm


subject: UNII:8KFO2187CP

object_name: endometrial cancer


subject: UNII:8KFO2187CP

object_name: uterine corpus cancer


subject: UNII:8KFO2187CP

object_name: endometrial carcinoma


subject: UNII:8KFO2187CP

object_name: non-small cell lung carcinoma


subject: UNII:8KFO2187CP

object_name: head and neck squamous cell carcinoma


subject: UNII:8KFO2187CP

object_name: triple-negative breast carcinoma


subject: UNII:8KFO2187CP

object_name: Triple-Negative Breast Cancer Finding


subject: UNII:8KFO2187CP

object_name: lymphoma, non-Hodgkin, familial


subject: UNII:8KFO2187CP

object_name: non-Hodgkin lymphoma


subject: UNII:8KFO2187CP

object_name: Adult Non-Hodgkin Lymphoma


subject: UNII:8KFO2187CP

object_name: Childhood Non-Hodgkin Lymphoma


subject: UNII:8KFO2187CP

object_name: malignant soft tissue neoplasm


subject: UNII:8KFO2187CP

object_name: sarcoma


subject: UMLS:C4724815

subject_name: ciforadenant

object_name: ovarian cancer


subject: UMLS:C4724815

object_name: ovarian neoplasm


subject: UMLS:C4724815

object_name: ovarian carcinoma


subject: UMLS:C4724815

object_name: bladder tumor


subject: UMLS:C4724815

object_name: urinary bladder carcinoma


subject: UMLS:C4724815

object_name: urinary bladder cancer


subject: UMLS:C4724815

object_name: childhood bladder carcinoma


subject: UMLS:C4724815

object_name: cervical cancer


subject: UMLS:C4724815

object_name: cervical carcinoma


subject: UMLS:C4724815

object_name: colorectal cancer


subject: UMLS:C4724815

object_name: colorectal carcinoma


subject: UMLS:C4724815

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: UMLS:C4724815

object_name: pancreatic neoplasm


subject: UMLS:C4724815

object_name: exocrine pancreatic carcinoma


subject: UMLS:C4724815

object_name: malignant pancreatic neoplasm


subject: UMLS:C4724815

object_name: endometrial cancer


subject: UMLS:C4724815

object_name: uterine corpus cancer


subject: UMLS:C4724815

object_name: endometrial carcinoma


subject: UMLS:C4724815

object_name: non-small cell lung carcinoma


subject: UMLS:C4724815

object_name: head and neck squamous cell carcinoma


subject: UMLS:C4724815

object_name: triple-negative breast carcinoma


subject: UMLS:C4724815

object_name: Triple-Negative Breast Cancer Finding


subject: UMLS:C4724815

object_name: lymphoma, non-Hodgkin, familial


subject: UMLS:C4724815

object_name: non-Hodgkin lymphoma


subject: UMLS:C4724815

object_name: Adult Non-Hodgkin Lymphoma


subject: UMLS:C4724815

object_name: Childhood Non-Hodgkin Lymphoma


subject: UMLS:C4724815

object_name: malignant soft tissue neoplasm


subject: UMLS:C4724815

object_name: sarcoma


subject: UMLS:C0308804

subject_name: Dexamethasone Sodium Phosphate Injection

object_name: peripheral vascular disease


subject: CHEBI:107736

subject_name: Metoclopramide

object_name: Physical trauma


subject: CHEBI:107736

object_name: Injury


subject: CHEBI:107736

object_name: Trauma


subject: CHEBI:107736

object_name: Opioid analgesic adverse reaction


subject: UMLS:C5417780

subject_name: KRT 232

object_name: Small cell lung cancer recurrent


subject: UMLS:C5417780

object_name: small cell lung carcinoma


subject: UMLS:C5417780

object_name: Small cell lung cancer extensive stage


subject: UniProtKB:P47802

subject_name: MTX1_MOUSE Metaxin-1 (sprot)

object_name: intraocular lymphoma


subject: PR:000010755


subject: UNII:AG9MHG098Z

subject_name: Zanubrutinib


subject: UMLS:C5400891

object_name: HIV infection


subject: CHEBI:231005

subject_name: 2-(Trifluoromethyl)isonicotinic acid

object_name: pancreatic neoplasm


subject: CHEBI:231005

object_name: exocrine pancreatic carcinoma


subject: CHEBI:231005

object_name: malignant pancreatic neoplasm


subject: CHEBI:231005

object_name: Stage II Pancreatic Cancer AJCC v6 and v7


subject: CHEBI:231005

object_name: Pancreatic carcinoma stage II


subject: CHEBI:231005

object_name: Stage IV Pancreatic Cancer AJCC v6 and v7


subject: CHEBI:231005

object_name: stage IV pancreatic cancer


subject: CHEBI:231005

object_name: Pancreatic carcinoma recurrent


subject: CHEBI:231005

object_name: Pancreatic carcinoma stage III


subject: CHEBI:231005

object_name: Stage III Pancreatic Cancer AJCC v6 and v7


subject: CHEBI:231005

object_name: pancreatic adenocarcinoma


subject: CHEBI:63587

subject_name: Eribulin


subject: CHEBI:63587


subject: CHEBI:63587


subject: CHEBI:63587


subject: CHEBI:63587


subject: CHEBI:63587


subject: CHEBI:63587


subject: CHEBI:63587


subject: CHEBI:63587


subject: CHEBI:63587


subject: CHEBI:63587


subject: CHEBI:40279

subject_name: Allopurinol

object_name: Multi vessel coronary artery disease


subject: CHEBI:40279

object_name: myocardial ischemia


subject: CHEBI:40279

object_name: Family history of ischemic heart disease


subject: MESH:C030259

subject_name: Broncho-Vaxom

object_name: Nephrotic syndrome in children


subject: DRUGBANK:DB16533


subject: CHEBI:8802

subject_name: Remifentanil

object_name: Insufficient Anesthesia


subject: PUBCHEM.COMPOUND:146346770

object_name: kidney failure


subject: UMLS:C3501102

object_name: major depressive disorder


subject: UMLS:C5226856

subject_name: lutikizumab

object_name: osteoarthritis, knee


subject: UMLS:C4329337

subject_name: TAB 001

object_name: Stage II Esophageal Squamous Cell Carcinoma AJCC v7


subject: UMLS:C4329337

object_name: Esophageal squamous cell carcinoma stage II


subject: UMLS:C4329337

object_name: Stage III Esophageal Squamous Cell Carcinoma AJCC v7


subject: UMLS:C4329337

object_name: Esophageal squamous cell carcinoma stage III


subject: UMLS:C4045694

object_name: end stage renal failure


subject: UMLS:C4045694

object_name: Chronic uremia


subject: UMLS:C4045694


subject: DRUGBANK:DB10640

subject_name: Beet

object_name: Raynaud disease


subject: CHEBI:16349

subject_name: Citrulline


subject: UNII:AWV6I5L6H2

subject_name: ANTITHROMBIN ALFA

object_name: Disseminated Intravascular Coagulation Related to COVID-19


subject: UNII:AWV6I5L6H2

object_name: disseminated intravascular coagulation


subject: UNII:AWV6I5L6H2

object_name: Disseminated Intravascular Coagulation, CTCAE


subject: UMLS:C2316217

subject_name: antithrombin alfa


subject: UMLS:C2316217


subject: UMLS:C2316217


subject: UMLS:C1579361

subject_name: Serotonin and Norepinephrine Reuptake Inhibitors (SNRIs)

object_name: Suicidal ideation


subject: UMLS:C1579361

object_name: Suicidal Ideation, CTCAE


subject: UMLS:C1579361

object_name: Cancer patients and suicide and depression


subject: UMLS:C1579361

object_name: Depressed - symptom


subject: UMLS:C1579361

object_name: Depression, CTCAE


subject: MESH:C000633847

object_name: type 2 diabetes mellitus


subject: MESH:C000633847

object_name: chronic kidney disease


subject: UMLS:C0017302

subject_name: General anesthetic drugs


subject: UMLS:C0017302

object_name: Dependence


subject: UMLS:C0017302

object_name: Frailty


subject: UMLS:C3536928

subject_name: General Anesthetic [EPC]


subject: UMLS:C3536928


subject: UMLS:C3536928


subject: UNII:ULS0NT2D68

subject_name: NECUPARANIB

object_name: Metastatic malignant neoplasm to pancreas


subject: PUBCHEM.COMPOUND:6096882

subject_name: indocyanine green

object_name: suppressor of tumorigenicity 3


subject: UNII:C4V974V932

subject_name: Indocyanine green acid form


subject: GTOPDB:9758

subject_name: camrelizumab

object_name: Esophageal Cancer by AJCC v8 Stage


subject: UNII:73096E137E


subject: UMLS:C4085979


subject: UNII:5S371K6132

subject_name: Rivoceranib


subject: PUBCHEM.COMPOUND:131704328

subject_name: Alginic acid

object_name: Overweight and obesity


subject: CHEBI:58187

subject_name: alginate


subject: UMLS:C0102137


subject: UMLS:C4733619

subject_name: Gallium Ga 68 PSMA-R2

object_name: metastatic prostate carcinoma


subject: CHEBI:25681

subject_name: Omega-3 fatty acids

object_name: Dry Eye Syndrome, CTCAE


subject: CHEBI:12777

subject_name: Vitamin A

object_name: xerophthalmia


subject: CHEBI:12777

object_name: dry eye syndrome


subject: CHEBI:12777


subject: CHEBI:27300

subject_name: Ergocalciferol


subject: CHEBI:27300


subject: CHEBI:3311

subject_name: Calcium carbonate

object_name: HIV-1 infection


subject: PUBCHEM.COMPOUND:2735

subject_name: Provitina


subject: PUBCHEM.COMPOUND:10883523

subject_name: vitamin D3


subject: UMLS:C3265062


subject: CHEBI:27300


subject: CHEBI:5134

subject_name: Fluticasone

object_name: Eczema, CTCAE


subject: CHEBI:5134

object_name: atopic eczema/dermatitis (non-specific)


subject: MESH:C539259

subject_name: EpiCeram


subject: UNII:T79C086548

subject_name: CONTEZOLID ACEFOSAMIL

object_name: gram-positive bacterial infections


subject: UNII:T79C086548

object_name: skin disease caused by bacterial infection


subject: UNII:T79C086548

object_name: cellulitis


subject: UMLS:C5418335

subject_name: Contezolid Acefosamil


subject: UMLS:C5418335


subject: UMLS:C5418335


subject: UNII:B72HH48FLU

subject_name: Infliximab

object_name: eosinophilic granulomatosis with polyangiitis


subject: CHEBI:125427


subject: UMLS:C3714610

subject_name: Calcitriol Drug Class


subject: CHEBI:17823

subject_name: Calcitriol


subject: CHEBI:38940

subject_name: Sunitinib

object_name: Recurrent Brain Neoplasm


subject: CHEBI:4672

subject_name: Docetaxel

object_name: Childhood Gastric Carcinoma


subject: PUBCHEM.COMPOUND:43805

subject_name: Oxaliplatin


subject: UMLS:C1314429

subject_name: INJECTION, OXALIPLATIN, 0.5 MG ADMINISTERED


subject: MESH:C079198

subject_name: S 1 (combination)


subject: GTOPDB:9209

subject_name: zolbetuximab


subject: GTOPDB:9209

object_name: gastric neoplasm


subject: UNII:TF5MPQ8WGY


subject: UNII:TF5MPQ8WGY


subject: UMLS:C2827697


subject: UMLS:C2827697


subject: CHEBI:135918

subject_name: Tucidinostat

object_name: Advanced Esophageal Carcinoma


subject: GTOPDB:9758

subject_name: camrelizumab


subject: UNII:73096E137E


subject: UMLS:C4085979


subject: UNII:5S371K6132

subject_name: Rivoceranib


subject: UNII:PF8K38CG54

subject_name: Fremanezumab

object_name: fibromyalgia


subject: UMLS:C3714111

object_name: High grade glioma


subject: UMLS:C3714111

object_name: Advanced cancer


subject: UMLS:C3714111

object_name: glioblastoma


subject: UMLS:C3714111

object_name: Childhood Glioblastoma


subject: UMLS:C3714111

object_name: adult glioblastoma


subject: CHEBI:62466

subject_name: Prolycopene

object_name: Stage II Prostate Cancer AJCC v6


subject: CHEBI:62466

object_name: Stage II Prostate Cancer AJCC v8


subject: CHEBI:62466

object_name: Carcinoma of the prostate stage II


subject: CHEBI:62466

object_name: Stage II Prostate Cancer AJCC v7


subject: CHEBI:62466

object_name: Stage I Prostate Cancer AJCC v6


subject: CHEBI:62466

object_name: Prostate cancer stage I


subject: CHEBI:62466

object_name: Stage I Prostate Cancer AJCC v8


subject: CHEBI:62466

object_name: Stage I Prostate Cancer AJCC v7


subject: CHEBI:62466

object_name: Stage III Prostate Cancer AJCC v8


subject: CHEBI:62466

object_name: Stage III Prostate Cancer AJCC v7


subject: CHEBI:62466

object_name: Carcinoma of the prostate stage III


subject: CHEBI:62466

object_name: Stage III Prostate Cancer AJCC v6


subject: CHEBI:15948

subject_name: Lycopene


subject: CHEBI:15948


subject: CHEBI:15948


subject: CHEBI:15948


subject: CHEBI:15948


subject: CHEBI:15948


subject: CHEBI:15948


subject: CHEBI:15948


subject: CHEBI:15948


subject: CHEBI:15948


subject: CHEBI:15948


subject: CHEBI:15948


subject: CHEBI:59527

object_name: Multiple sclerosis relapse


subject: CHEBI:91939

subject_name: (R)-Naproxen


subject: CHEBI:7476

subject_name: Naproxen


subject: CHEBI:17650

subject_name: Hydrocortisone

object_name: Decreased cardiac output


subject: UMLS:C5706530

subject_name: BNT 313

object_name: Adult Solid Neoplasm


subject: CHEBI:31759

subject_name: Lafutidine

object_name: chronic gastritis


subject: CHEBI:93775

subject_name: Amethopterin

object_name: primary biliary cholangitis


subject: CHEBI:50681


subject: CHEBI:44185

subject_name: Methotrexate


subject: CHEBI:135466

subject_name: Nafamostat

object_name: acute kidney failure


subject: CHEBI:135466

object_name: Acute Kidney Injury, CTCAE


subject: UMLS:C0207682

subject_name: nafamostat mesilate


subject: UMLS:C0207682


subject: CHEBI:75929

object_name: Smoker


subject: CHEBI:40009

subject_name: Cycloserine


subject: UMLS:C0085297

subject_name: immunoglobulins, intravenous

object_name: pregnancy related


subject: UMLS:C0392939

subject_name: recombinant human thrombopoietin


subject: UNII:04XB9TB8OL

object_name: asthma


subject: UNII:04XB9TB8OL

object_name: Rhinovirus infection


subject: UNII:04XB9TB8OL

object_name: Picornaviridae infectious disease


subject: UNII:04XB9TB8OL

object_name: common cold


subject: CHEBI:50005

subject_name: trans-stilbene oxide

object_name: ulcerative colitis


subject: GTOPDB:13396

subject_name: ivonescimab

object_name: cervical cancer


subject: GTOPDB:13396

object_name: cervical carcinoma


subject: GTOPDB:13396

object_name: endometrial cancer


subject: GTOPDB:13396

object_name: uterine corpus cancer


subject: GTOPDB:13396

object_name: endometrial carcinoma


subject: UNII:Y0O332CU66

subject_name: IVONESCIMAB


subject: UNII:Y0O332CU66


subject: UNII:Y0O332CU66


subject: UNII:Y0O332CU66


subject: UNII:Y0O332CU66


subject: UMLS:C5669600

subject_name: Ivonescimab


subject: UMLS:C5669600


subject: UMLS:C5669600


subject: UMLS:C5669600


subject: MESH:C438308

subject_name: recombinant FVIII, sugar formulated

object_name: hemophilia A


subject: UMLS:C5139949

object_name: Hepatic impairment


subject: UNII:73SM5SF3OR

subject_name: Abrocitinib


subject: CHEBI:2549

subject_name: Albuterol

object_name: childhood asthma with status asthmaticus


subject: CHEBI:33704

subject_name: Amino acid

object_name: traumatic encephalopathy


subject: CHEBI:33704

object_name: traumatic brain injury


subject: PUBCHEM.COMPOUND:169449957

subject_name: Amino Acids


subject: PUBCHEM.COMPOUND:169449957


subject: CHEMBL.COMPOUND:CHEMBL1201498

subject_name: AMINO ACIDS


subject: CHEMBL.COMPOUND:CHEMBL1201498


subject: UMLS:C3539946

subject_name: Amino Acids, I.V. solution additive


subject: UMLS:C3539946


subject: UMLS:C0002520


subject: UMLS:C0002520


subject: UMLS:C3539947

subject_name: Antifibrinolytic amino acids


subject: UMLS:C3539947


subject: CHEBI:16414

subject_name: Valine


subject: CHEBI:16414


subject: CHEBI:68534

subject_name: Enzalutamide


subject: CHEBI:68534

object_name: Coronavinae infectious disease


subject: GTOPDB:12652

subject_name: magrolimab

object_name: metastatic colorectal cancer


subject: UNII:90YIEHRFJ9


subject: UMLS:C3896840


subject: UMLS:C4329330

object_name: Advanced breast cancer


subject: UMLS:C0350411

subject_name: Oxygen only product in gas for inhalation

object_name: lung disorder


subject: UMLS:C0350411

object_name: History of - respiratory disease


subject: CHEBI:33283

subject_name: THIAMINE

object_name: cardiac arrest


subject: CHEBI:33283

object_name: Cardiac Arrest, CTCAE


subject: CHEBI:33283

object_name: Shock


subject: UMLS:C3714802

subject_name: Thiamine Drug Class


subject: UMLS:C3714802


subject: UMLS:C3714802


subject: CHEBI:18385

subject_name: Thiamine


subject: CHEBI:18385


subject: CHEBI:18385


subject: GTOPDB:8221

subject_name: epacadostat

object_name: Plexosarcoma


subject: UNII:2HR315841W


subject: CHEMBL.COMPOUND:CHEMBL3833369

subject_name: FISH OIL

object_name: relapsing-remitting multiple sclerosis


subject: CHEBI:71272

subject_name: Saxagliptin

object_name: Type 2 diabetes mellitus (T2D)


subject: CHEBI:35218

subject_name: anthocyanin cation

object_name: Presenile dementia


subject: CHEBI:35218

object_name: dementia


subject: CHEBI:35218

object_name: mild neurocognitive disorder


subject: CHEBI:35218

object_name: mild cognitive impairment


subject: CHEBI:35218

object_name: coronary artery disorder


subject: CHEBI:35218

object_name: coronary atherosclerosis


subject: CHEBI:35218

object_name: Inflammation


subject: CHEBI:36121

subject_name: flavylium


subject: CHEBI:36121


subject: CHEBI:36121


subject: CHEBI:36121


subject: CHEBI:36121


subject: UNII:52CMI0WC3Y

subject_name: Atezolizumab

object_name: Metastatic papillary renal cell carcinoma (disorder)


subject: UNII:52CMI0WC3Y

object_name: Metastatic Papillary Renal Cell Carcinoma


subject: UMLS:C3827082


subject: UMLS:C3827082


subject: UNII:AF75XOF6W3

subject_name: Relatlimab

object_name: Adult Soft Tissue Sarcoma


subject: UMLS:C3827149


subject: UNII:KM31LBX59H

subject_name: Florbenazine F-18

object_name: Alzheimer disease


subject: UNII:KM31LBX59H

object_name: Lewy Bodies


subject: UMLS:C2934037


subject: UMLS:C2934037


subject: UMLS:C2974798

object_name: Parkinson disease


subject: UMLS:C2974798


subject: UMLS:C2974798


subject: CHEBI:63791

subject_name: Lenalidomide

object_name: grade 3B follicular lymphoma


subject: CHEBI:63791

object_name: Epstein-Barr virus-positive diffuse large B-cell lymphoma of the elderly


subject: CHEBI:4636

subject_name: Diphenhydramine

object_name: dystocia


subject: CHEBI:2922

subject_name: Auranofin

object_name: Recurrent Fallopian Tube Carcinoma


subject: CHEBI:2922

object_name: recurrent primary peritoneal cavity cancer


subject: MESH:C000722213

object_name: adult lymphoma


subject: MESH:C000722213

object_name: lymphoma


subject: MESH:C000722213

object_name: pediatric lymphoma


subject: MESH:C000722213

object_name: Advanced cancer


subject: UNII:S9J80L3D1U

subject_name: PELAREOREP

object_name: Carcinoma breast stage IV


subject: UMLS:C5401064

object_name: Advanced Malignant Solid Neoplasm


subject: UMLS:C5401064

object_name: head and neck squamous cell carcinoma


subject: UMLS:C5401064

object_name: triple-negative breast carcinoma


subject: UMLS:C5401064

object_name: Triple-Negative Breast Cancer Finding


subject: UMLS:C5401064

object_name: non-small cell lung carcinoma


subject: UMLS:C5401064

object_name: fallopian tube carcinoma


subject: UMLS:C5401064

object_name: fallopian tube cancer


subject: UMLS:C5401064

object_name: squamous cell carcinoma


subject: UMLS:C5401064

object_name: colorectal cancer


subject: UMLS:C5401064

object_name: colorectal carcinoma


subject: UMLS:C5401064

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: UMLS:C5401064

object_name: Carcinoma of peritoneum


subject: UMLS:C5401064

object_name: peritoneal carcinoma


subject: UMLS:C5401064

object_name: ovarian cancer


subject: UMLS:C5401064

object_name: ovarian carcinoma


subject: UMLS:C5401064

object_name: malignant epithelial tumor of ovary


subject: CHEBI:50730

subject_name: Montelukast

object_name: coronary atherosclerosis


subject: CHEBI:49807

object_name: amyotrophic lateral sclerosis


subject: CHEBI:25016

subject_name: lead atom


subject: CHEBI:53319

subject_name: polybutadiene macromolecule


subject: CHEBI:60686

subject_name: polybutadiene polymer


subject: PUBCHEM.COMPOUND:121488172

subject_name: Tozuleristide

object_name: Childhood Central Nervous System Neoplasm


subject: UNII:835UH424TU


subject: UMLS:C1832024

subject_name: fermented wheat germ extract


subject: UMLS:C1832024

object_name: ovarian neoplasm


subject: UMLS:C1832024


subject: CHEBI:57694

object_name: severe acute respiratory syndrome


subject: CHEBI:16243

subject_name: Quercetin


subject: UNII:GKF8S4C432

subject_name: Anlotinib

object_name: exocrine pancreatic carcinoma


subject: UNII:GKF8S4C432

object_name: Her2-receptor negative breast cancer


subject: UNII:GKF8S4C432

object_name: cholangiocarcinoma


subject: CHEBI:9316

subject_name: Sufentanil

object_name: Pelvic Floor Disorders


subject: CHEBI:9316

object_name: Prolonged labor


subject: CHEBI:9316

object_name: History of - prolonged labor


subject: UMLS:C5670729

subject_name: Actinium Ac 225-DOTA-Daratumumab

object_name: Plasma cell myeloma refractory


subject: UMLS:C5670729

object_name: Plasma cell myeloma recurrent


subject: UMLS:C5670731

subject_name: Indium In 111-DOTA-Daratumumab


subject: UMLS:C5670731


subject: CHEBI:184662

object_name: immune reconstitution inflammatory syndrome


subject: CHEMBL.COMPOUND:CHEMBL256907

subject_name: maraviroc


subject: CHEBI:63608

subject_name: Maraviroc


subject: UNII:V7I58RC5EJ

subject_name: monomethyl auristatin E

object_name: Pancreatic carcinoma non-resectable


subject: UMLS:C1565020


subject: PUBCHEM.COMPOUND:21976333

subject_name: MMAE


subject: GTOPDB:9592

subject_name: tislelizumab

object_name: PD-L1 Combined Positive Score Less than 5


subject: GTOPDB:9592

object_name: PD-L1 Combined Positive Score Greater than or Equal to 5


subject: CHEMBL.COMPOUND:CHEMBL4297840

subject_name: TISLELIZUMAB


subject: CHEMBL.COMPOUND:CHEMBL4297840


subject: UMLS:C4053664


subject: UMLS:C4053664


subject: PUBCHEM.COMPOUND:73151030

subject_name: Empagliflozin

object_name: epilepsy


subject: GTOPDB:6596

subject_name: etaracizumab

object_name: colorectal cancer


subject: GTOPDB:6596

object_name: colorectal carcinoma


subject: GTOPDB:6596

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: UNII:41W9MFI160


subject: UNII:41W9MFI160


subject: UNII:41W9MFI160


subject: UMLS:C1135124


subject: UMLS:C1135124


subject: UMLS:C1135124


subject: CHEBI:357241

subject_name: glycinexylidide

object_name: infertility


subject: CHEBI:357241

object_name: Encounter due to In vitro fertilization


subject: PR:000013661

subject_name: Ras-related C3 botulinum toxin substrate 2


subject: PR:000013661


subject: PR:000035208

subject_name: elongation factor P--(R)-beta-lysine ligase


subject: PR:000035208


subject: CHEBI:72296

subject_name: Apixaban

object_name: Anticoagulant-induced bleeding


subject: CHEBI:85974

subject_name: edoxaban tosylate hydrate


subject: PUBCHEM.COMPOUND:11635624

subject_name: Edoxaban


subject: CHEBI:10033

subject_name: Warfarin


subject: UNII:QMS40680K6

subject_name: Palifermin

object_name: multiple sclerosis


subject: CHEBI:135947

subject_name: Bazedoxifene

object_name: Depressed mood


subject: CHEBI:135947

object_name: Cancer patients and suicide and depression


subject: CHEBI:135947

object_name: Depressed - symptom


subject: CHEBI:135947

object_name: Depression, CTCAE


subject: CHEBI:135947

object_name: Perimenopausal disorder


subject: PUBCHEM.COMPOUND:45357473

subject_name: Estratab


subject: PUBCHEM.COMPOUND:45357473


subject: PUBCHEM.COMPOUND:45357473


subject: PUBCHEM.COMPOUND:45357473


subject: PUBCHEM.COMPOUND:45357473


subject: CHEBI:180911

object_name: prostate cancer


subject: CHEBI:180911

object_name: prostate neoplasm


subject: CHEBI:45906

subject_name: Suramin


subject: CHEBI:45906


subject: CHEBI:3423

subject_name: Carmustine

object_name: Adult Brain Glioblastoma


subject: CHEBI:3423

object_name: Recurrent Adult Brain Neoplasm


subject: PUBCHEM.COMPOUND:11332179

subject_name: pasireotide

object_name: hyperglycemia


subject: PUBCHEM.COMPOUND:11332179

object_name: Hyperglycemia, CTCAE


subject: PUBCHEM.COMPOUND:11332179

object_name: Glucose in blood specimen above reference range


subject: CHEBI:25805

subject_name: oxygen atom

object_name: pulmonary edema


subject: CHEBI:25805

object_name: Pulmonary Edema, CTCAE


subject: CHEBI:25805

object_name: lung disorder


subject: CHEBI:15379

subject_name: Oxygen


subject: CHEBI:15379


subject: CHEBI:15379


subject: UNII:YNH9K62UXU

subject_name: EFAVALEUKIN ALFA

object_name: EXCESS LMW-DNA


subject: UMLS:C4687718

subject_name: Fc il-2 mutein fusion protein (amg-592)


subject: UMLS:C5418103

subject_name: Anti-PD-L1 Monoclonal Antibody RC98

object_name: Stomach cancer


subject: UMLS:C5418103

object_name: gastric cancer


subject: CHEBI:71200

subject_name: Tofacitinib

object_name: polyarticular juvenile idiopathic arthritis


subject: CHEBI:71200

object_name: psoriasis-related juvenile idiopathic arthritis


subject: PUBCHEM.COMPOUND:6096882

subject_name: indocyanine green

object_name: childhood kidney neoplasm


subject: PUBCHEM.COMPOUND:6096882

object_name: Metastatic Ewing's Sarcoma


subject: PUBCHEM.COMPOUND:6096882

object_name: soft tissue sarcoma


subject: PUBCHEM.COMPOUND:6096882

object_name: Metastatic osteosarcoma


subject: PUBCHEM.COMPOUND:6096882

object_name: Secondary malignant neoplasm of lung


subject: PUBCHEM.COMPOUND:6096882

object_name: Adult Rhabdomyosarcoma


subject: PUBCHEM.COMPOUND:6096882

object_name: rhabdomyosarcoma


subject: PUBCHEM.COMPOUND:6096882

object_name: Childhood Rhabdomyosarcoma


subject: PUBCHEM.COMPOUND:6096882

object_name: Previously Treated Childhood Rhabdomyosarcoma


subject: UNII:C4V974V932

subject_name: Indocyanine green acid form


subject: UNII:C4V974V932


subject: UNII:C4V974V932


subject: UNII:C4V974V932


subject: UNII:C4V974V932


subject: UNII:C4V974V932


subject: UNII:C4V974V932


subject: UNII:C4V974V932


subject: UNII:C4V974V932


subject: CHEMBL.COMPOUND:CHEMBL3545208

object_name: Nociceptive Pain


subject: CHEMBL.COMPOUND:CHEMBL3545208

object_name: Peripheral neuropathic pain


subject: CHEBI:157844

subject_name: Glu-Arg

object_name: inherited lipid metabolism disorder


subject: CHEBI:157844

object_name: Dyslipidemia


subject: CHEBI:157844

object_name: Primary hypercholesterolemia


subject: CHEBI:33379

subject_name: erbium


subject: CHEBI:33379


subject: CHEBI:33379


subject: UMLS:C5441529

subject_name: Estrogen Receptor Family, human


subject: UMLS:C5441529


subject: UMLS:C5441529


subject: PR:000007204

subject_name: estrogen receptor


subject: PR:000007204


subject: PR:000007204


subject: HMDB:HMDB0256702

subject_name: Porfimer Sodium

object_name: Disseminated Malignant Neoplasm


subject: HMDB:HMDB0256702

object_name: Embolism, Tumor


subject: HMDB:HMDB0256702

object_name: Neoplasm Metastasis


subject: UNII:Y3834SIK5F

subject_name: PORFIMER SODIUM


subject: UNII:Y3834SIK5F


subject: UNII:Y3834SIK5F


subject: UNII:687805287F

subject_name: Fozivudine Tidoxil

object_name: HIV infection


subject: CHEBI:7773

subject_name: Ondansetron

object_name: Pregnant


subject: MESH:D010919

subject_name: Placebos

object_name: Cystic fibrosis pulmonary exacerbation


subject: CHEBI:8382

subject_name: Prednisone


subject: CHEBI:91398

subject_name: Tivantinib

object_name: pancreatic neoplasm


subject: UMLS:C0964361

subject_name: SonoVue

object_name: prostate neoplasm


subject: CHEBI:30496

subject_name: Sulfur hexafluoride


subject: UMLS:C3714501

subject_name: Insulin Drug Class

object_name: Vascular Stiffness


subject: CHEBI:5931

subject_name: insulin human


subject: CHEBI:7726

subject_name: octreotide

object_name: Insulin Sensitivity


subject: CHEBI:7726


subject: CHEBI:4466

subject_name: Dexmedetomidine

object_name: ear infection


subject: UNII:7N8K34P2XH

subject_name: Detomidine


subject: CHEBI:17154

subject_name: Nicotinamide

object_name: Niacinamide adverse reaction


subject: CHEBI:63584

subject_name: Cabazitaxel

object_name: bladder transitional cell carcinoma


subject: CHEBI:233321

subject_name: Mitoquinone

object_name: Fatigue, CTCAE 5.0


subject: CHEBI:233321

object_name: Fatigue


subject: CHEBI:233321

object_name: multiple sclerosis


subject: CHEBI:31355

subject_name: Carboplatin

object_name: esophageal disorder


subject: CHEBI:71157

subject_name: Dobesilic acid

object_name: type 2 diabetes mellitus


subject: CHEBI:71157

object_name: Pulmonary function (finding)


subject: MESH:C513826

subject_name: Xue-Fu-Zhu-Yu decoction


subject: MESH:C513826


subject: CHEBI:6801

subject_name: Metformin


subject: CHEBI:139072


subject: CHEBI:139072

object_name: Burnout, Caregiver


subject: CHEBI:139072

object_name: Moral Injury


subject: CHEBI:8614

subject_name: Psilocybin


subject: CHEBI:8614


subject: CHEBI:8614


subject: UNII:KX89J0DFZ8

subject_name: IMSIDOLIMAB

object_name: Acneiform Eruptions


subject: UMLS:C0249056


subject: PUBCHEM.COMPOUND:155142

subject_name: Sustanon 250

object_name: Muscle Atrophy


subject: PUBCHEM.COMPOUND:155142

object_name: sarcopenia


subject: CHEBI:5523

subject_name: Goserelin


subject: CHEBI:5523


subject: UMLS:C0149473

subject_name: Zoladex


subject: UMLS:C0149473


subject: CHEBI:30884

subject_name: glycoloyl group

object_name: rheumatoid arthritis


subject: CHEBI:73890

subject_name: Gly-Cys


subject: CHEBI:135515

subject_name: Bendamustine

object_name: Light chain (AL) amyloidosis


subject: CHEBI:135515

object_name: amyloidosis


subject: UNII:R30772KCU0

subject_name: Isatuximab


subject: UNII:R30772KCU0


subject: UMLS:C2983777


subject: UMLS:C2983777


subject: UNII:I8309403R0

subject_name: Peginterferon beta-1a


subject: UNII:I8309403R0

object_name: severe acute respiratory syndrome


subject: UMLS:C4721408

subject_name: Substance with receptor antagonist mechanism of action (substance)

object_name: prostate neoplasm


subject: CHEBI:132922

object_name: Androgen excess


subject: CHEBI:43415

subject_name: Dexibuprofen


subject: CHEBI:5855

subject_name: Ibuprofen


subject: UMLS:C5666919

subject_name: Anti-c-Met ADC ABBV-400

object_name: esophageal squamous cell carcinoma


subject: UMLS:C5666919

object_name: triple-negative breast carcinoma


subject: UMLS:C5666919

object_name: Triple-Negative Breast Cancer Finding


subject: UMLS:C5666919

object_name: pancreatic ductal adenocarcinoma


subject: UMLS:C5666919

object_name: biliary tract cancer


subject: UMLS:C5666919

object_name: liver carcinoma


subject: CHEBI:94366

subject_name: itraconazole


subject: CHEBI:94366


subject: CHEBI:94366


subject: CHEBI:94366


subject: MESH:C000633847

object_name: Chronic Kidney Disease, CTCAE


subject: UMLS:C2348411

object_name: Childhood Breast Carcinoma


subject: UMLS:C2348411

object_name: breast carcinoma


subject: UMLS:C2348411

object_name: breast cancer


subject: UMLS:C2348411

object_name: Stomach cancer


subject: UMLS:C2348411

object_name: gastric cancer


subject: CHEBI:231702

subject_name: Tirbanibulin


subject: CHEBI:231702


subject: CHEBI:231702


subject: CHEBI:231702


subject: CHEBI:231702


subject: CHEBI:231702

object_name: unspecified adult solid tumor, protocol specific


subject: PUBCHEM.COMPOUND:149063248

subject_name: FLOTUFOLASTAT

object_name: prostate carcinoma


subject: PUBCHEM.COMPOUND:149063248

object_name: prostate cancer


subject: UNII:AHU547PI9H

subject_name: Ferric derisomaltose

object_name: Pelvis fracture


subject: UNII:AHU547PI9H

object_name: Hip Fracture, CTCAE


subject: UNII:AHU547PI9H

object_name: hip fracture


subject: UNII:N02W67RKJS

object_name: neurotoxicity


subject: UNII:N02W67RKJS

object_name: cancer


subject: UNII:N02W67RKJS

object_name: neoplasm


subject: UNII:P28BIW0UTB

subject_name: FODIPIR


subject: UNII:P28BIW0UTB


subject: UNII:P28BIW0UTB


subject: PUBCHEM.COMPOUND:76967443

subject_name: Mangafodipir


subject: PUBCHEM.COMPOUND:76967443


subject: PUBCHEM.COMPOUND:76967443


subject: CHEBI:45783

subject_name: Imatinib

object_name: Myeloid Metaplasia


subject: UMLS:C3463874

object_name: pneumonia


subject: UMLS:C3463874

object_name: COVID-19-Associated Pneumonia


subject: UNII:I031V2H011

subject_name: Tocilizumab

object_name: follicular lymphoma


subject: CHEBI:201431

subject_name: Cyclosporin H

object_name: Diabetes


subject: CHEBI:201431

object_name: diabetes mellitus


subject: CHEBI:4031

subject_name: Cyclosporine


subject: CHEBI:4031


subject: CHEBI:8426

subject_name: Probenecid


subject: CHEBI:8426


subject: UMLS:C3641866

object_name: prostate neoplasm


subject: UMLS:C1527137

subject_name: Recombinant melatonin

object_name: Postoperative delirium


subject: CHEBI:16796

subject_name: Melatonin


subject: UMLS:C3710112

subject_name: Salvadora persica root extract

object_name: periodontitis, chronic, adult


subject: UMLS:C3710112

object_name: chronic periodontitis


subject: UMLS:C5783505

subject_name: Anti-C5 Monoclonal Antibody/Complement Factor H 1-5 Domain Fusion Protein KP104

object_name: EXCESS LMW-DNA


subject: CHEBI:74926

subject_name: Patulin

object_name: Myelodysplasia


subject: CHEBI:74926

object_name: acute myeloid leukemia by FAB classification


subject: CHEBI:74926

object_name: acute myeloid leukemia


subject: CHEBI:74926

object_name: acute lymphoblastic leukemia


subject: CHEBI:74926

object_name: chronic myelogenous leukemia, BCR-ABL1 positive


subject: UMLS:C5666957

subject_name: Anti-PD-1/Anti-CD3 Bispecific Antibody ONO-4685

object_name: Chronic small plaque psoriasis


subject: DRUGBANK:DB15786

subject_name: Maritime pine extract

object_name: coronary artery disorder


subject: DRUGBANK:DB15786

object_name: coronary atherosclerosis


subject: UMLS:C0072642

subject_name: Pycnogenol


subject: UMLS:C0072642


subject: CHEBI:90

subject_name: Epicatechin

object_name: obesity due to melanocortin 4 receptor deficiency


subject: CHEBI:90

object_name: obesity


subject: CHEBI:90

object_name: Obesity, CTCAE


subject: CHEBI:15600

subject_name: Cianidanol


subject: CHEBI:15600


subject: CHEBI:15600


subject: PUBCHEM.COMPOUND:21881649


subject: PUBCHEM.COMPOUND:21881649


subject: PUBCHEM.COMPOUND:21881649


subject: PUBCHEM.COMPOUND:108065

subject_name: proanthocyanidin


subject: PUBCHEM.COMPOUND:108065


subject: PUBCHEM.COMPOUND:108065


subject: CHEBI:166895

subject_name: procyanidin


subject: CHEBI:166895


subject: CHEBI:166895


subject: UMLS:C1449695

subject_name: Procyanidins


subject: UMLS:C1449695


subject: UMLS:C1449695


subject: DRUGBANK:DB16615

subject_name: Krill oil

object_name: hypertrophy


subject: PUBCHEM.COMPOUND:146624881

subject_name: DIVARASIB

object_name: metastatic colorectal cancer


subject: UNII:E6S21PVT91


subject: UNII:L4C1UY2NYH

subject_name: Inavolisib


subject: PUBCHEM.COMPOUND:146662729


subject: UNII:TW6044C3O6


subject: UNII:E3B2GI648A

subject_name: Belatacept

object_name: Immunosuppression


subject: UNII:E3B2GI648A

object_name: Decreased Immunologic Activity [PE]


subject: CHEBI:90225

subject_name: Rubitecan

object_name: prostate carcinoma


subject: CHEBI:90225

object_name: prostate cancer


subject: CHEBI:4672

subject_name: Docetaxel

object_name: Stage IIA Prostate Cancer AJCC v7


subject: CHEBI:4672

object_name: Stage IIA Prostate Cancer AJCC v8


subject: CHEBI:4672

object_name: Stage IIB Prostate Cancer AJCC v8


subject: CHEBI:4672

object_name: Stage IIB Prostate Cancer AJCC v7


subject: CHEBI:62466

subject_name: Prolycopene

object_name: Prostate cancer recurrent


subject: CHEBI:62466


subject: CHEBI:62466


subject: CHEBI:62466


subject: CHEBI:62466


subject: CHEBI:15948

subject_name: Lycopene


subject: CHEBI:15948


subject: CHEBI:15948


subject: CHEBI:15948


subject: CHEBI:15948


subject: CHEMBL.COMPOUND:CHEMBL1201574

subject_name: ONABOTULINUMTOXINA

object_name: headache migraine chronic


subject: UMLS:C3827065

object_name: malignant glioma


subject: PUBCHEM.COMPOUND:134506

subject_name: Dehydroandrosterone

object_name: Addison Disease


subject: CHEBI:28689

subject_name: Prasterone


subject: CHEBI:114785

subject_name: Erlotinib

object_name: Metastasis


subject: CHEBI:114785

object_name: Metastatic Lesion


subject: PUBCHEM.COMPOUND:70789204

subject_name: Everolimus


subject: CHEBI:49603

subject_name: Lapatinib


subject: CHEBI:31596

subject_name: Febuxostat

object_name: diabetic kidney disease


subject: CHEBI:32016

subject_name: Pirfenidone

object_name: Myocardial fibrosis


subject: PUBCHEM.COMPOUND:121489720

subject_name: darolutamide

object_name: Oligometastasis


subject: PUBCHEM.COMPOUND:121489720


subject: PUBCHEM.COMPOUND:121489720

object_name: Disseminated Malignant Neoplasm


subject: PUBCHEM.COMPOUND:121489720

object_name: Embolism, Tumor


subject: PUBCHEM.COMPOUND:121489720

object_name: Neoplasm Metastasis


subject: CHEBI:6121

subject_name: Ketamine

object_name: cholecystitis


subject: CHEBI:6121

object_name: Cholecystitis, CTCAE 3.0


subject: CHEBI:6121

object_name: Cholecystitis, CTCAE 5.0


subject: CHEBI:88316

subject_name: Nefopam


subject: CHEBI:88316


subject: CHEBI:88316


subject: UNII:LOG73M21H5

subject_name: SUZETRIGINE

object_name: Fractured rib


subject: CHEBI:233446

subject_name: suzetrigine


subject: UMLS:C2713028

subject_name: ABI 009

object_name: Leigh syndrome


subject: UNII:3I798OGQ8B

subject_name: Fluorofuranylnorprogesterone F-18


subject: UNII:3I798OGQ8B


subject: UNII:3I798OGQ8B


subject: UNII:3I798OGQ8B

object_name: breast lobular carcinoma


subject: UMLS:C1707048

subject_name: broccoli sprout extract

object_name: Atopic rhinitis


subject: CHEBI:232556

subject_name: Erdafitinib

object_name: Refractory Bladder Carcinoma


subject: CHEBI:232556

object_name: Refractory Bladder Urothelial Carcinoma


subject: CHEBI:232556

object_name: FGFR Gene Mutation


subject: CHEBI:232556

object_name: FGFR2 Gene Mutation


subject: CHEBI:232556

object_name: Platinum-Resistant Urothelial Carcinoma


subject: CHEBI:232556

object_name: FGFR2 Gene Amplification


subject: MESH:D000077203

subject_name: Sodium-Glucose Transporter 2 Inhibitors

object_name: Hypervolemia


subject: UMLS:C3542461

subject_name: Sodium-Glucose Cotransporter 2 Inhibitor [EPC]


subject: CHEBI:109549

subject_name: Ramelteon

object_name: Cirrhosis


subject: CHEBI:109549

object_name: liver cirrhosis


subject: UNII:5S371K6132

subject_name: Rivoceranib

object_name: glioma


subject: UMLS:C0873019

subject_name: Berberine hydrochloride

object_name: gastric intestinal metaplasia


subject: CHEBI:95341

subject_name: Baricitinib

object_name: chronic kidney disease


subject: PUBCHEM.COMPOUND:2307

subject_name: Andion

object_name: bronchopulmonary dysplasia


subject: PUBCHEM.COMPOUND:2307

object_name: Bronchopulmonary Dysplasia, AE


subject: PUBCHEM.COMPOUND:2307

object_name: lung disorder


subject: PUBCHEM.COMPOUND:2307

object_name: congenital alveolar dysplasia


subject: PUBCHEM.COMPOUND:2307

object_name: respiratory distress syndrome in premature infants


subject: PUBCHEM.COMPOUND:2307

object_name: newborn respiratory distress syndrome


subject: CHEBI:3001

subject_name: beclomethasone


subject: CHEBI:3001


subject: CHEBI:3001


subject: CHEBI:3001


subject: CHEBI:3001


subject: CHEBI:3001


subject: CHEBI:6933

subject_name: Midodrine

object_name: fibrosis


subject: CHEBI:7726

subject_name: octreotide


subject: UMLS:C5417992

subject_name: Tobemstomig

object_name: melanoma


subject: UNII:8H61Y4E29N

subject_name: Ortataxel

object_name: glioblastoma


subject: UNII:8H61Y4E29N

object_name: Childhood Glioblastoma


subject: UNII:8H61Y4E29N

object_name: adult glioblastoma


subject: UMLS:C0700551

subject_name: aminohippurate sodium

object_name: acute kidney failure


subject: UMLS:C0700551

object_name: Acute Kidney Injury, CTCAE


subject: UMLS:C0935929

subject_name: Antidiabetics

object_name: hyperglycemia


subject: UMLS:C0935929

object_name: Hyperglycemia, CTCAE


subject: UMLS:C0935929

object_name: Glucose in blood specimen above reference range


subject: CHEBI:63610

subject_name: Misoprostol

object_name: Consent Type - Hysterectomy


subject: UNII:EJC4C3UYXH

subject_name: ANDROGEN RECEPTOR

object_name: hypertension


subject: UNII:EJC4C3UYXH

object_name: Hypertension, CTCAE


subject: UNII:EJC4C3UYXH

object_name: prostate carcinoma


subject: UNII:EJC4C3UYXH

object_name: prostate cancer


subject: UNII:EJC4C3UYXH

object_name: dysautonomia


subject: UNII:EJC4C3UYXH

object_name: autonomic nervous system disorder


subject: UNII:EJC4C3UYXH

object_name: kidney disorder


subject: CHEBI:137238

subject_name: Ala-Arg


subject: CHEBI:137238


subject: CHEBI:137238


subject: CHEBI:137238


subject: CHEBI:137238


subject: CHEBI:137238


subject: CHEBI:137238


subject: CHEBI:49474


subject: CHEBI:49474


subject: CHEBI:49474


subject: CHEBI:49474


subject: CHEBI:49474


subject: CHEBI:49474


subject: CHEBI:49474


subject: UMLS:C1999216

subject_name: Inhibitor


subject: UMLS:C1999216


subject: UMLS:C1999216


subject: UMLS:C1999216


subject: UMLS:C1999216


subject: UMLS:C1999216


subject: UMLS:C1999216


subject: PUBCHEM.COMPOUND:53481562

subject_name: Gonadotropin-Releasing Hormone


subject: PUBCHEM.COMPOUND:53481562


subject: PUBCHEM.COMPOUND:53481562


subject: PUBCHEM.COMPOUND:53481562


subject: PUBCHEM.COMPOUND:53481562


subject: CHEBI:5520

subject_name: gonadorelin


subject: CHEBI:5520


subject: CHEBI:5520


subject: CHEBI:5520


subject: CHEBI:5520


subject: PR:000008127


subject: PR:000008127


subject: PR:000008127


subject: PR:000008127


subject: PR:000008127


subject: UMLS:C0306166

subject_name: Factrel


subject: UMLS:C0306166


subject: UMLS:C0306166


subject: UMLS:C0306166


subject: UMLS:C0306166


subject: CHEBI:77069

subject_name: Eperisone

object_name: Low back pain


subject: CHEBI:8892

object_name: DIABETES MELLITUS NON INSULIN DEPENDENT ORAL AGENT THERAPY


subject: CHEBI:135530

subject_name: Solifenacin

object_name: Stress urinary incontinence


subject: CHEBI:85994

subject_name: Lenvatinib

object_name: Small cell lung cancer extensive stage


subject: CHEBI:94534

subject_name: olanzapine

object_name: End stage cancer


subject: CHEBI:42941

object_name: cholangiocarcinoma


subject: CHEBI:42797

subject_name: Gabapentin

object_name: Tinnitus, Subjective


subject: UNII:9G6U5L461Q

subject_name: Icotinib

object_name: esophageal cancer


subject: UNII:9G6U5L461Q

object_name: Childhood Esophageal Carcinoma


subject: UNII:9G6U5L461Q

object_name: neoplasm of esophagus


subject: CHEBI:34730

subject_name: doxycycline hyclate

object_name: mucositis


subject: PUBCHEM.COMPOUND:54671203

subject_name: doxycycline


subject: CHEMBL.COMPOUND:CHEMBL5314982

subject_name: ECISKAFUSP ALFA

object_name: Solid Neoplasm


subject: UMLS:C5446873


subject: CHEBI:60791

subject_name: Xylocard

object_name: liver neoplasm


subject: CHEBI:60791

object_name: Adult Liver Carcinoma


subject: CHEBI:60791

object_name: liver carcinoma


subject: UMLS:C0086466

subject_name: Injectables


subject: UMLS:C0086466


subject: UMLS:C0086466


subject: RXCUI:8375

subject_name: placebo Oral Tablet

object_name: chronic pain (diagnosis)


subject: RXCUI:8375

object_name: Chronic pain


subject: UMLS:C4045694

object_name: hyperphosphatemia


subject: UMLS:C4045694

object_name: Serum phosphate concentrations above normal (finding)


subject: UMLS:C4045694

object_name: Hyperphosphatemia, CTCAE


subject: PUBCHEM.COMPOUND:156963654

subject_name: Sacituzumab govitecan

object_name: small cell carcinoma


subject: PUBCHEM.COMPOUND:156963654

object_name: small cell lung carcinoma


subject: UNII:DA64T2C2IO

subject_name: SACITUZUMAB


subject: UMLS:C3640943


subject: PUBCHEM.COMPOUND:53477758

subject_name: Oxytocin

object_name: Social anxiety


subject: UMLS:C0592155

subject_name: Syntocinon


subject: CHEBI:3311

subject_name: Calcium carbonate

object_name: chronic kidney disease


subject: CHEBI:70839

subject_name: Dasatinib

object_name: transitional cell carcinoma


subject: CHEBI:190514


subject: CHEBI:49375


subject: CHEBI:6456

subject_name: Lidocaine

object_name: hematoma


subject: CHEBI:6456

object_name: Hematoma, CTCAE


subject: CHEBI:6456

object_name: Distal Radius Fractures


subject: UNII:4Z63YK6E0E

subject_name: Daratumumab

object_name: EXCESS LMW-DNA


subject: CHEBI:63610

subject_name: Misoprostol

object_name: labor; forced or induced, affecting fetus or newborn


subject: CHEBI:94782

subject_name: Cediranib

object_name: Small cell lung cancer extensive stage


subject: UNII:68AYS9A614

subject_name: CEDIRANIB MALEATE


subject: UMLS:C2711999

subject_name: cediranib maleate


subject: UMLS:C0001645

subject_name: Adrenergic beta-Antagonists

object_name: Blood Pressure Finding


subject: UMLS:C0001645

object_name: Systemic arterial pressure


subject: CHEBI:35498

subject_name: diuretic


subject: CHEBI:35498


subject: UMLS:C0012798

subject_name: Diuretics


subject: UMLS:C0012798


subject: UMLS:C5399719

subject_name: Diuretic [APC]


subject: UMLS:C5399719


subject: CHEBI:139349

subject_name: ACAA

object_name: rosacea


subject: UMLS:C0724198

subject_name: VANICREAM


subject: CHEBI:37941

subject_name: Clopidogrel

object_name: Metastatic malignant neoplasm to pancreas


subject: CHEBI:37941

object_name: pancreatic adenocarcinoma


subject: CHEBI:18394

subject_name: Palatinose

object_name: type 2 diabetes mellitus


subject: UNII:V59P50X4UY

subject_name: isomaltulose


subject: GTOPDB:13716

subject_name: disitamab vedotin

object_name: biliary tract cancer


subject: GTOPDB:13716

object_name: liver carcinoma


subject: UNII:RB3U3A1S27

subject_name: DISITAMAB VEDOTIN


subject: UNII:RB3U3A1S27


subject: UMLS:C4329329


subject: UMLS:C4329329


subject: UMLS:C0003442

subject_name: lymphocyte immune globulin, anti-thymocyte globulin

object_name: Recurrent Severe Aplastic Anemia


subject: UMLS:C0003442

object_name: Refractory Severe Aplastic Anemia


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate


subject: CHEBI:4026


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: CHEBI:4027


subject: PUBCHEM.COMPOUND:4739

subject_name: Vidarbine


subject: PUBCHEM.COMPOUND:4739


subject: CHEBI:229687


subject: CHEBI:229687


subject: CHEBI:27834

subject_name: Pentostatin


subject: CHEBI:27834


subject: CHEBI:6933

subject_name: Midodrine

object_name: Hepatic hydrothorax


subject: CHEBI:17045

subject_name: Nitrous oxide

object_name: amnesia


subject: CHEBI:17045

object_name: Amnesia, CTCAE


subject: CHEBI:8774

subject_name: Ramipril

object_name: myocardial ischemia


subject: UMLS:C3896927

object_name: B-cell chronic lymphocytic leukemia


subject: UMLS:C0107343

subject_name: BSS plus

object_name: cataract


subject: UMLS:C0107343

object_name: Cataract, CTCAE 3.0


subject: UMLS:C0107343

object_name: Cataract, CTCAE 5.0


subject: UMLS:C0107343

object_name: cataract on exam (physical finding)


subject: UMLS:C0107343

object_name: Fuchs' endothelial dystrophy


subject: UNII:Q2U4R164OG

object_name: asthma


subject: PUBCHEM.COMPOUND:66555816

object_name: Adult Solid Neoplasm


subject: UNII:QI52W1ZIIB


subject: CHEBI:188074

object_name: hypertriglyceridemia


subject: CHEBI:188074

object_name: Hypertriglyceridemia, CTCAE


subject: CHEBI:50122

subject_name: Rosiglitazone


subject: CHEBI:50122


subject: CHEBI:64073

object_name: obesity due to congenital leptin deficiency


subject: CHEBI:64073

object_name: obesity due to leptin receptor gene deficiency


subject: CHEBI:64073

object_name: morbid obesity


subject: UNII:9P1872D4OL

subject_name: Exenatide


subject: UNII:9P1872D4OL


subject: UNII:9P1872D4OL


subject: CHEBI:135826

subject_name: Octenidine

object_name: gingivitis


subject: UMLS:C1314412

subject_name: INJECTION, ALEFACEPT, 0.5 MG ADMINISTERED

object_name: sickle cell disease


subject: UMLS:C1314412

object_name: severe congenital neutropenia


subject: UMLS:C1314412

object_name: Leukocyte adhesion deficiency


subject: UMLS:C1314412

object_name: leukocyte adhesion deficiency 1


subject: UMLS:C1314412

object_name: Shwachman-Diamond syndrome


subject: UMLS:C1314412

object_name: Severe Aplastic Anemia


subject: UMLS:C1314412

object_name: severe aplastic anemia


subject: UMLS:C1314412

object_name: Thrombasthenia


subject: UMLS:C1314412

object_name: Diamond-Blackfan anemia


subject: UMLS:C1314412

object_name: Aase syndrome


subject: UMLS:C1314412

object_name: Chediak-Higashi syndrome


subject: UMLS:C1314412

object_name: Wiskott-Aldrich syndrome


subject: UMLS:C1314412

object_name: Fanconi anemia


subject: UMLS:C1314412

object_name: Fanconi anemia complementation group A


subject: UMLS:C1314412

object_name: thalassemia


subject: UNII:ELK3V90G6C

subject_name: Alefacept


subject: UNII:ELK3V90G6C


subject: UNII:ELK3V90G6C


subject: UNII:ELK3V90G6C


subject: UNII:ELK3V90G6C


subject: UNII:ELK3V90G6C


subject: UNII:ELK3V90G6C


subject: UNII:ELK3V90G6C


subject: UNII:ELK3V90G6C


subject: UNII:ELK3V90G6C


subject: UNII:ELK3V90G6C


subject: UNII:ELK3V90G6C


subject: UNII:ELK3V90G6C


subject: UNII:ELK3V90G6C


subject: UNII:ELK3V90G6C


subject: UNII:D7RD81HE4W

subject_name: thymoglobulin

object_name: Solid Neoplasm


subject: UMLS:C0359156

subject_name: Thymoglobulin


subject: PUBCHEM.COMPOUND:3080587

subject_name: Megestrol

object_name: Stage IIIC2 Uterine Corpus Cancer AJCC v7


subject: PUBCHEM.COMPOUND:3080587

object_name: Stage IIIC1 Uterine Corpus Cancer AJCC v7


subject: CHEBI:41774

subject_name: Tamoxifen

object_name: endometrial carcinoma


subject: CHEBI:41774


subject: CHEBI:41774


subject: CHEBI:41774

object_name: Stage IIIA Uterine Corpus Cancer AJCC v7


subject: CHEBI:41774

object_name: Stage IIIB Uterine Corpus Cancer AJCC v7


subject: CHEBI:41774

object_name: Stage IVB Uterine Corpus Cancer AJCC v7


subject: CHEBI:41774

object_name: Stage IVA Uterine Corpus Cancer AJCC v7


subject: CHEBI:79699

subject_name: Temsirolimus


subject: CHEBI:79699


subject: CHEBI:229221

subject_name: Fruquintinib

object_name: gastroesophageal cancer


subject: PR:000013574

subject_name: sulfhydryl oxidase 1


subject: UNII:1K8M7UR6O1

subject_name: Yttrium Y-90

object_name: Embolism, Tumor


subject: UNII:1K8M7UR6O1

object_name: Neoplasm Metastasis


subject: UNII:1K8M7UR6O1

object_name: Metastatic Lesion


subject: UNII:GKF8S4C432

subject_name: Anlotinib

object_name: Advanced Bile Duct Carcinoma


subject: UMLS:C4744993


subject: MESH:C520255

subject_name: 130-nm albumin-bound paclitaxel


subject: UMLS:C0699319

subject_name: Cytoxan

object_name: bone cancer


subject: CHEBI:64816

object_name: Ewing sarcoma


subject: UNII:3A58010674

subject_name: Pegfilgrastim


subject: CHEBI:76842

object_name: subarachnoid hemorrhage


subject: CHEBI:28001

subject_name: Vancomycin


subject: UNII:3H8GSZ4SQL

subject_name: Avatrombopag

object_name: Chronic liver disease


subject: UMLS:C0013227

subject_name: Pharmaceutical Preparations


subject: UMLS:C0013227

object_name: Thrombocytopenia caused by drugs


subject: UMLS:C0178601

subject_name: Dopamine Agonists

object_name: Parkinson disease


subject: UMLS:C3536925

subject_name: Dopaminergic Agonist [EPC]


subject: CHEBI:63791

subject_name: Lenalidomide

object_name: fallopian tube cancer


subject: CHEBI:63791

object_name: peritoneum cancer


subject: CHEBI:32090

subject_name: Rebamipide

object_name: ankylosing spondylitis


subject: CHEBI:32090

object_name: osteoarthritis


subject: UMLS:C4330595

subject_name: GL-0817 Vaccine

object_name: oral cavity squamous cell carcinoma


subject: DRUGBANK:DB17293

subject_name: Hiltonol


subject: UNII:7KYP9TKT70

subject_name: poly ICLC


subject: UNII:5TAA004E22

subject_name: Sargramostim


subject: PR:000005931


subject: UMLS:C3493856

object_name: neuralgia


subject: CHEBI:62088

subject_name: Metamizole

object_name: post operative nausea and vomiting


subject: UMLS:C3489617

object_name: Childhood Breast Carcinoma


subject: UMLS:C3489617

object_name: breast carcinoma


subject: UMLS:C3489617

object_name: breast cancer


subject: CHEBI:23359

subject_name: colchicine

object_name: plasma cell myeloma


subject: CHEBI:41423

subject_name: Celecoxib

object_name: familial adenomatous polyposis 1


subject: CHEBI:51141

subject_name: Alfuzosin

object_name: Urinary Calculi


subject: UMLS:C3826869

subject_name: SOM230 LAR

object_name: ectopic ACTH secretion syndrome


subject: UMLS:C3826869

object_name: pancreatic neoplasm


subject: UMLS:C3826869

object_name: malignant pancreatic neoplasm


subject: UMLS:C3826869

object_name: pituitary cancer


subject: UMLS:C3826869

object_name: Nelson syndrome


subject: UMLS:C5439905

object_name: Immune Deficiency Disease


subject: CHEBI:6970

subject_name: Mometasone

object_name: chronic rhinitis


subject: UMLS:C2003425

object_name: bipolar disorder


subject: UMLS:C2003425

object_name: bipolar depression


subject: CHEBI:145500

subject_name: thiencarbazone-methyl

object_name: rectal carcinoma


subject: CHEBI:145500

object_name: rectal cancer


subject: CHEBI:145500

object_name: Childhood Rectal Carcinoma


subject: CHEBI:35255

subject_name: Chloroform


subject: CHEBI:35255


subject: CHEBI:35255


subject: CHEBI:60775

subject_name: Verteporfin

object_name: breast neoplasm


subject: CHEMBL.COMPOUND:CHEMBL5314346

subject_name: VERTEPORFIN


subject: PUBCHEM.COMPOUND:54671203

subject_name: doxycycline

object_name: lateral epicondylitis of bilateral elbows


subject: PUBCHEM.COMPOUND:54671203

object_name: Medial epicondylitis of right elbow joint


subject: PUBCHEM.COMPOUND:54671203

object_name: Medial epicondylitis of left elbow joint


subject: PUBCHEM.COMPOUND:54671203

object_name: Lateral epicondylitis, unspecified elbow


subject: PUBCHEM.COMPOUND:54671203

object_name: lateral epicondylitis of right elbow


subject: PUBCHEM.COMPOUND:54671203

object_name: lateral epicondylitis of left elbow


subject: PUBCHEM.COMPOUND:54671203

object_name: epicondylitis


subject: PUBCHEM.COMPOUND:24755620

subject_name: Sacubitril valsartan

object_name: sleep apnea


subject: PUBCHEM.COMPOUND:24755620

object_name: heart failure


subject: UNII:688RNR55GH

subject_name: SACUBITRIL VALSARTAN


subject: UNII:688RNR55GH


subject: UMLS:C4033631

subject_name: sacubitril / valsartan


subject: UNII:7B646RJ70F

subject_name: Peldesine

object_name: HIV infection


subject: UMLS:C0718247

subject_name: Active brand of pseudoephedrine-triprolidine

object_name: long COVID-19


subject: UMLS:C5907919

subject_name: Allogeneic Anti-B7-H3 CAR Gamma Delta T-cells QH104

object_name: Intracranial glioma


subject: UMLS:C5907919

object_name: glioblastoma


subject: UNII:3K6A6FJ98O

subject_name: Preimplantation factor

object_name: autoimmune hepatitis


subject: UMLS:C3489950

subject_name: preimplantation factor, synthetic


subject: MESH:D011819

subject_name: Rabies Vaccines

object_name: Dog Bite


subject: MESH:D011819

object_name: reported bite by dog (history)


subject: CHEMBL.COMPOUND:CHEMBL2107909

subject_name: RABIES VACCINE


subject: CHEMBL.COMPOUND:CHEMBL2107909


subject: CHEBI:134767

subject_name: Valnoctamide

object_name: Schizoaffective disorder, manic type


subject: CHEBI:134767

object_name: Mania, CTCAE


subject: CHEBI:134767

object_name: Mania


subject: CHEBI:6888

subject_name: Methylprednisolone

object_name: Esophageal stricture


subject: CHEBI:6888

object_name: Esophageal stenosis


subject: CHEBI:6888

object_name: Esophageal Stenosis, CTCAE


subject: CHEBI:6888

object_name: Pharyngeal Stenosis


subject: CHEBI:6888

object_name: Pharyngeal Stenosis, CTCAE


subject: CHEBI:6888

object_name: Esophageal injury caused by alkali


subject: PUBCHEM.COMPOUND:155543961

subject_name: LIRAGLUTIDE

object_name: binge eating


subject: UMLS:C1099192


subject: UNII:G6UF363ECX

object_name: Adenocarcinoma of the prostate metastatic


subject: CHEBI:45716

subject_name: Vorinostat

object_name: Stage IVB Prostate Cancer AJCC v8


subject: CHEBI:45716


subject: UNII:64WR8KN4FV

subject_name: BIFIDOBACTERIUM BREVE BIF195

object_name: irritable bowel syndrome


subject: CHEBI:136046

subject_name: Ripasudil

object_name: Fuchs


subject: UMLS:C4521107

object_name: myeloproliferative neoplasm


subject: UMLS:C4521107

object_name: Malignant myeloproliferative neoplasm


subject: UMLS:C4521107

object_name: Myelodysplasia


subject: UMLS:C4521107

object_name: Adult Myelodysplastic Syndrome


subject: UMLS:C4521107

object_name: childhood myelodysplastic syndrome


subject: UMLS:C4521107

object_name: Myelodysplastic Syndrome, CTCAE


subject: UMLS:C4521107

object_name: plasma cell myeloma


subject: UMLS:C4521107

object_name: acute lymphoblastic leukemia


subject: UMLS:C4521107

object_name: non-Hodgkin lymphoma


subject: UMLS:C4521107

object_name: lymphoma, non-Hodgkin, familial


subject: UMLS:C4521107

object_name: Adult Non-Hodgkin Lymphoma


subject: UMLS:C4521107

object_name: Childhood Non-Hodgkin Lymphoma


subject: UMLS:C4521107

object_name: Hodgkin Disease


subject: PUBCHEM.COMPOUND:166625217

subject_name: MOTIXAFORTIDE


subject: PUBCHEM.COMPOUND:166625217


subject: PUBCHEM.COMPOUND:166625217


subject: PUBCHEM.COMPOUND:166625217


subject: PUBCHEM.COMPOUND:166625217


subject: PUBCHEM.COMPOUND:166625217


subject: PUBCHEM.COMPOUND:166625217


subject: PUBCHEM.COMPOUND:166625217


subject: PUBCHEM.COMPOUND:166625217


subject: PUBCHEM.COMPOUND:166625217


subject: PUBCHEM.COMPOUND:166625217


subject: PUBCHEM.COMPOUND:166625217


subject: CHEBI:137235


subject: PR:000012200

subject_name: transmembrane prolyl 4-hydroxylase


subject: UMLS:C4727777

object_name: hyperparathyroidism


subject: UMLS:C4727777

object_name: Hyperparathyroidism, CTCAE


subject: PUBCHEM.COMPOUND:57389748

subject_name: Linagliptin

object_name: Type 2 diabetes mellitus with established diabetic nephropathy


subject: CHEBI:229469

subject_name: Sulodexide


subject: CHEBI:9434

subject_name: Telmisartan


subject: CHEBI:9667

subject_name: Triamcinolone

object_name: Keloidal surgical scar


subject: UMLS:C4724252

subject_name: fluorouracil injection

object_name: keloid


subject: UMLS:C4724252


subject: UMLS:C5960296

subject_name: p53 Y220C Reactivator JAB-30355

object_name: Solid Neoplasm


subject: MESH:C000592636

subject_name: er-zhi-wan

object_name: Hypercholesterolemia


subject: UMLS:C4725022

subject_name: PKC-beta Inhibitor MS-553

object_name: Aggressive Non-Hodgkin Lymphoma


subject: PUBCHEM.COMPOUND:71226663

subject_name: Acalabrutinib


subject: UNII:O43472U9X8

subject_name: Obinutuzumab


subject: CHEBI:133021

subject_name: Venetoclax


subject: UMLS:C0065828

subject_name: Measles-Mumps-Rubella Vaccine

object_name: plantar wart


subject: UMLS:C0065828

object_name: common wart


subject: GTOPDB:13663

subject_name: ponsegromab

object_name: pancreatic neoplasm


subject: GTOPDB:13663

object_name: exocrine pancreatic carcinoma


subject: GTOPDB:13663

object_name: malignant pancreatic neoplasm


subject: GTOPDB:13663

object_name: colorectal cancer


subject: GTOPDB:13663

object_name: colorectal carcinoma


subject: GTOPDB:13663

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: GTOPDB:13663

object_name: non-small cell lung carcinoma


subject: GTOPDB:13663

object_name: Anorexia


subject: GTOPDB:13663

object_name: Anorexia symptom


subject: GTOPDB:13663

object_name: Poor appetite


subject: GTOPDB:13663

object_name: Fatigue, CTCAE 5.0


subject: GTOPDB:13663

object_name: Fatigue


subject: UNII:GXA6PF0254

subject_name: PONSEGROMAB


subject: UNII:GXA6PF0254


subject: UNII:GXA6PF0254


subject: UNII:GXA6PF0254


subject: UNII:GXA6PF0254


subject: UNII:GXA6PF0254


subject: UNII:GXA6PF0254


subject: UNII:GXA6PF0254


subject: UNII:GXA6PF0254


subject: UNII:GXA6PF0254


subject: UNII:GXA6PF0254


subject: UNII:GXA6PF0254


subject: UMLS:C5446872

subject_name: Ponsegromab


subject: UMLS:C5446872


subject: UMLS:C5446872


subject: UMLS:C5446872


subject: UMLS:C5446872


subject: UMLS:C5446872


subject: CHEBI:161680

subject_name: Aztreonam

object_name: gonorrhea


subject: CHEBI:161680

object_name: Gonorrhea of pharynx